European Health
Information Gateway

Tutorials and first steps
Gateway Country profiles Data
Data
Indicators Explorer
Tutorials and first steps Visit the main WHO website?
EN
  • en
  • ru
Databases
European Health for All database (HFA-DB) Artificial Intelligence for Health in the WHO European Region Assistive Technology European Programme of Work Digital Health European mortality database (MDB) Rehabilitation Health-enhancing physical activity European database on human and technical resources for health (HlthRes-DB) Environment and Health Information System (ENHIS) Financial protection in the European Region
  • en
  • ru
Monitoring
Child and adolescent health Seasonal influenza vaccination policies and coverage
  • en
  • ru
Reporting
Health Behaviour in School-aged Children (HBSC) Maternal nutrition, physical activity and weight gain during pregnancy Antimicrobial resistance Global nutrition policy survey Status of child and adolescent health policies in Europe
  • en
  • ru
Archive
Health 2020 indicators Global eHealth survey 2015 Joint Monitoring Framework (JMF)
  • en
  • ru
Data Databases Monitoring Reporting Archive
Tutorials and first steps Visit the main WHO website?
  • en
  • ru
Gateway
Indicators Explorer
Info

Indicators Explorer

This data explorer contains indicators from WHO Europe’s Health for All family of databases – European Health for All database (HFA), European Mortality Indicator Database (MDB), and European database on human and technical resources for health (HRes). The data in the databases is collected by WHO Europe in collaboration with the Member States in the WHO European region, and from other relevant international data sources.

puzzle
integrated data
Get familiar with integrated data and browse through all databases in one place
click on target
Interact
Interact with the data and see dynamic changes over time and geographic place
search summary text
Search
Search through the indicators by topic or a title
export feature icon
export
If you need to export the data, metadata, graphs or share them online
Explorer
Start researching

Saved charts

Saved charts
  • Albania
  • Andorra
  • Armenia
  • Austria
  • Azerbaijan
  • Belarus
  • Belgium
  • Belgium (Bruxelles)
  • Belgium (Flanders)
  • Belgium (Wallonia)
  • Bosnia and Herzegovina
  • Bulgaria
  • Canada
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Georgia
  • Germany
  • Greece
  • Greenland
  • Hungary
  • Iceland
  • Ireland
  • Israel
  • Italy
  • Kazakhstan
  • Kyrgyzstan
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Monaco
  • Montenegro
  • Netherlands
  • North Macedonia
  • Norway
  • Poland
  • Portugal
  • Republic of Moldova
  • Romania
  • Russian Federation
  • San Marino
  • Serbia
  • Serbia
  • Serbia and Montenegro
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • Tajikistan
  • Türkiye
  • Turkmenistan
  • Ukraine
  • United Kingdom
  • United Kingdom (England)
  • United Kingdom (Northern Ireland)
  • United Kingdom (Scotland)
  • United Kingdom (Wales)
  • USA
  • Uzbekistan
  • Kosovo[1]
  • WHO European Region
  • Members of the European Union
  • Members of the EU before May 2004 (EU15)
  • Members of the EU after May 2004 (EU13)
  • Members of the EU before Feb 2020
  • Commonwealth of Independent States
  • Central Asian Republics Information Network members (CARINFONET)
  • South-eastern Europe Health Network members (SEEHN)
  • Nordic countries
  • Small countries
  • HBSC countries
  • WHO Euro surveillance countries
  • Western Balkans
Selected options:
0
Indicators (2589)
Select one or more indicator to visualize data. Filter through subjects or pick a database you are interested in.
Indicator groups
Indicators
  • Associate professional nurses, professionally active, head count
  • Associate professional nurses, professionally active, per 10 000 population
  • Professional nurses, professionally active, head count
  • Professional nurses, professionally active, per 10 000 population
  • Professionally active nurses, per 10 000 population
  • Total professionally active nurses, head count
  • Annual average rate of inflation (%)
  • Area (km2)
  • Availability of social support
  • Average population density per km2
  • Crude death rate per 1000 population
  • Crude death rate per 1000 population, females
  • Crude death rate per 1000 population, males
  • Disability-adjusted life expectancy
  • Disability-adjusted life expectancy, females
  • Disability-adjusted life expectancy, males
  • Estimated infant mortality per 1000 live births (world health report)
  • Estimated life expectancy at birth
  • Estimated life expectancy at birth, females
  • Estimated life expectancy at birth, males
  • Estimated probability of dying before age 5, per 1000 live births (world health report)
  • GINI coefficient (income distribution)
  • Gross domestic product (GDP), US$ per capita
  • Gross national income, US$ per capita
  • Labour force as % of population
  • Life expectancy at age 1 (years)
  • Life expectancy at age 1 (years), females
  • Life expectancy at age 1 (years), males
  • Life expectancy at age 15 (years)
  • Life expectancy at age 15 (years), females
  • Life expectancy at age 15 (years), males
  • Life expectancy at age 45 (years)
  • Life expectancy at age 45 (years), females
  • Life expectancy at age 45 (years), males
  • Life expectancy at age 65 (years)
  • Life expectancy at age 65 (years), females
  • Life expectancy at age 65 (years), males
  • Life expectancy at birth (years)
  • Life expectancy at birth (years), females
  • Life expectancy at birth (years), males
  • Literacy rate (%) in female population aged 15+ years
  • Literacy rate (%) in male population aged 15+ years
  • Literacy rate (%) in population aged 15+ years
  • Live births per 1000 population
  • Live births per 1000 population, females
  • Live births per 1000 population, males
  • Number of live births
  • Number of live births, females
  • Number of live births, males
  • Probability of dying before age 5 per 1000 live births, females
  • Probability of dying before age 5 per 1000 live births, males
  • Proportion of children of official primary school age not enrolled, both sexes
  • Proportion of children of official primary school age not enrolled, females
  • Proportion of children of official primary school age not enrolled, males
  • Real gross domestic product, PPP$ per capita
  • Reduction of life expectancy through death before 65 years
  • Reduction of life expectancy through death before 65 years, females
  • Reduction of life expectancy through death before 65 years, males
  • Total fertility rate
  • Total government expenditure as % of GDP
  • UNDP Human Development Index (HDI)
  • Unemployment rate (%)
  • Youth unemployment rate, % of labor force ages 15-24, female
  • Youth unemployment rate, % of labor force ages 15-24, male
  • Youth unemployment rate, % of total labor force ages 15-24
  • % of population aged 0–14 years
  • % of population aged 0–14 years, females
  • % of population aged 0–14 years, males
  • % of population aged 65+ years
  • % of population aged 65+ years, females
  • % of population aged 65+ years, males
  • % of population with postsecondary education aged 25+ years
  • % of population with primary education only aged 25+ years
  • % of population with secondary education only aged 25+ years
  • % of urban population
  • Pharmacists licensed to practice, head count
  • Pharmacists licensed to practice, per 10 000 population
  • Practising pharmacists, head count
  • Practising pharmacists, per 10 000 population
  • Professionally active pharmacists, head count
  • Professionally active pharmacists, per 10 000 population
  • Physicians licensed to practice, head count
  • Physicians licensed to practice, per 10 000 population
  • Practising physicians, head count
  • Practising physicians, per 10 000 population
  • Professionally active physicians, head count
  • Professionally active physicians, per 10 000 population
  • Physicians, both sexes, 35–44 years old
  • Physicians, both sexes, 45–54 years old
  • Physicians, both sexes, 55–64 years old
  • Physicians, both sexes, 65 years old or older
  • Physicians, both sexes, all ages
  • Physicians, both sexes, younger than 35 years
  • % of physicians by sex, all ages
  • % of physicians, both sexes, 35–44 years old
  • % of physicians, both sexes, 45–54 years old
  • % of physicians, both sexes, 55–64 years old
  • % of physicians, both sexes, 65 years old or older
  • % of physicians, both sexes, younger than 35 years
  • General paediatricians, head count
  • General paediatricians, per 10 000 population
  • General practitioners, head count
  • General practitioners, per 10 000 population
  • Generalist medical practitioners, head count
  • Generalist medical practitioners, per 10 000 population
  • Medical doctors not further defined, head count
  • Medical doctors not further defined, per 10 000 population
  • Medical group of specialists, head count
  • Medical group of specialists, per 10 000 population
  • Obstetricians and gynaecologists, head count
  • Obstetricians and gynaecologists, per 10 000 population
  • Other generalist (non–specialist) medical practitioners, head count
  • Other generalist (non–specialist) medical practitioners, per 10 000 population
  • Other specialists not elsewhere classified, head count
  • Other specialists not elsewhere classified, per 10 000 population
  • Psychiatrists, head count
  • Psychiatrists, per 10 000 population
  • Specialist medical practitioners, head count
  • Specialist medical practitioners, per 10 000 population
  • Surgical group of specialists, head count
  • Surgical group of specialists, per 10 000 population
  • Practising physiotherapists, head count
  • Practising physiotherapists, per 10 000 population
  • Number of reported episodes of illness attributable to diseases carried in drinking-water
  • Number of reported outbreaks of diseases arising from drinking-water
  • Population with house connections to piped water
  • Population connected to wastewater treatment facilities
  • Population with home connection to improved sanitation facilities
  • Bathing water quality for coastal zones in EU countries, levels of compliance
  • Bathing water quality for freshwater zones in EU countries
  • Numbers of people aged 0–24 years injured in road traffic accidents per 100 000 motor vehicles
  • Standardized death rates (three-year average) for road traffic injuries in people aged 0–24 years
  • Standardized road traffic injury rates in people aged 0–24 years
  • Early neonatal deaths per 1000 live births
  • Healthy life expectancy (HALE ) at birth, female
  • Healthy life expectancy (HALE) at birth
  • Healthy life expectancy (HALE) at birth, male
  • Number of maternal deaths, clinical data
  • Probability of dying before age 5 per 1000 live births
  • SDR all causes, all ages, per 100 000
  • SDR, acute respiratory infections, pneumonia and influenza, under 5 years, per 100 000
  • SDR, acute respiratory infections, pneumonia and influenza, under 5 years, per 100 000, females
  • SDR, acute respiratory infections, pneumonia and influenza, under 5 years, per 100 000, males
  • SDR, all causes, 0–64, per 100 000
  • SDR, all causes, 0–64, per 100 000, females
  • SDR, all causes, 0–64, per 100 000, males
  • SDR, all causes, 65+, per 100 000
  • SDR, all causes, 65+, per 100 000, females
  • SDR, all causes, 65+, per 100 000, males
  • SDR, all causes, all ages, per 100 000, females
  • SDR, all causes, all ages, per 100 000, males
  • SDR, bronchitis/emphysema/asthma, 0–64, per 100 000
  • SDR, bronchitis/emphysema/asthma, 0–64, per 100 000, females
  • SDR, bronchitis/emphysema/asthma, 0–64, per 100 000, males
  • SDR, bronchitis/emphysema/asthma, all ages, per 100 000
  • SDR, bronchitis/emphysema/asthma, all ages, per 100 000, females
  • SDR, bronchitis/emphysema/asthma, all ages, per 100 000, males
  • SDR, cancer of the cervix uteri, 0–64, per 100 000
  • SDR, cancer of the cervix uteri, 65+, per 100 000
  • SDR, cancer of the cervix uteri, all ages, per 100 000
  • SDR, cerebrovascular diseases, 0–64, per 100 000
  • SDR, cerebrovascular diseases, 0–64, per 100 000, males
  • SDR, cerebrovascular diseases, 0–64, per 100 000,females
  • SDR, cerebrovascular diseases, 65+, per 100 000
  • SDR, cerebrovascular diseases, 65+, per 100 000, females
  • SDR, cerebrovascular diseases, 65+, per 100 000, males
  • SDR, cerebrovascular diseases, all ages, per 100 000
  • SDR, cerebrovascular diseases, all ages, per 100 000, females
  • SDR, cerebrovascular diseases, all ages, per 100 000, males
  • SDR, chronic liver disease and cirrhosis, 0–64, per 100 000
  • SDR, chronic liver disease and cirrhosis, 0–64, per 100 000, females
  • SDR, chronic liver disease and cirrhosis, 0–64, per 100 000, males
  • SDR, chronic liver disease and cirrhosis, all ages, per 100 000
  • SDR, chronic liver disease and cirrhosis, all ages, per 100 000, females
  • SDR, chronic liver disease and cirrhosis, all ages, per 100 000, males
  • SDR, diabetes mellitus, 0–64, per 100 000
  • SDR, diabetes mellitus, 0–64, per 100 000, females
  • SDR, diabetes mellitus, 0–64, per 100 000, males
  • SDR, diabetes mellitus, all ages, per 100 000, females
  • SDR, diabetes mellitus, all ages, per 100 000, males
  • SDR, diabetes, all ages, per 100 000
  • SDR, diarrhoeal diseases, under 5 years, per 100 000
  • SDR, diarrhoeal diseases, under 5 years, per 100 000, females
  • SDR, diarrhoeal diseases, under 5 years, per 100 000, males
  • SDR, digestive diseases, 30-69 years, both sexes
  • SDR, digestive diseases, 30-69 years, females
  • SDR, digestive diseases, 30-69 years, males
  • SDR, disease of genitourinary system, 0–64, per 100 000
  • SDR, disease of genitourinary system, 0–64, per 100 000, females
  • SDR, disease of genitourinary system, 0–64, per 100 000, males
  • SDR, disease of genitourinary system, all ages, per 100 000
  • SDR, disease of genitourinary system, all ages, per 100 000, females
  • SDR, disease of genitourinary system, all ages, per 100 000, males
  • SDR, diseases of circulatory system, 0–64, per 100 000
  • SDR, diseases of circulatory system, 0–64, per 100 000, females
  • SDR, diseases of circulatory system, 0–64, per 100 000, males
  • SDR, diseases of circulatory system, 65+, per 100 000
  • SDR, diseases of circulatory system, 65+, per 100 000, females
  • SDR, diseases of circulatory system, 65+, per 100 000, males
  • SDR, diseases of circulatory system, all ages, per 100 000
  • SDR, diseases of circulatory system, all ages, per 100 000, females
  • SDR, diseases of circulatory system, all ages, per 100 000, males
  • SDR, diseases of digestive system, 0–64, per 100 000
  • SDR, diseases of digestive system, 0–64, per 100 000, females
  • SDR, diseases of digestive system, 0–64, per 100 000, males
  • SDR, diseases of digestive system, 65+, per 100 000
  • SDR, diseases of digestive system, 65+, per 100 000, females
  • SDR, diseases of digestive system, 65+, per 100 000, males
  • SDR, diseases of digestive system, all ages, per 100 000
  • SDR, diseases of digestive system, all ages, per 100 000, females
  • SDR, diseases of digestive system, all ages, per 100 000, males
  • SDR, diseases of respiratory system, 0–64, per 100 000
  • SDR, diseases of respiratory system, 0–64, per 100 000, females
  • SDR, diseases of respiratory system, 0–64, per 100 000, males
  • SDR, diseases of respiratory system, 65+, per 100 000
  • SDR, diseases of respiratory system, 65+, per 100 000, females
  • SDR, diseases of respiratory system, 65+, per 100 000, males
  • SDR, diseases of respiratory system, all ages, per 100 000
  • SDR, diseases of respiratory system, all ages, per 100 000, females
  • SDR, diseases of respiratory system, all ages, per 100 000, males
  • SDR, diseases of the blood, blood forming organs and certain immunity disorders, 0–64, per 100 000
  • SDR, diseases of the blood, blood forming organs and certain immunity disorders, 0–64, per 100 000, females
  • SDR, diseases of the blood, blood forming organs and certain immunity disorders, 0–64, per 100 000, males
  • SDR, diseases of the blood, blood forming organs and certain immunity disorders, all ages, per 100 000
  • SDR, diseases of the blood, blood forming organs and certain immunity disorders, all ages, per 100 000, females
  • SDR, diseases of the blood, blood forming organs and certain immunity disorders, all ages, per 100 000, males
  • SDR, endocrine, nutritional and metabolic diseases, all ages, per 100 000
  • SDR, endocrine/nutrition/metabolic disease/disorder involving immune mechanism, 0–64, per 100 000
  • SDR, endocrine/nutrition/metabolic disease/disorder involving immune mechanism, 0–64, per 100 000, females
  • SDR, endocrine/nutrition/metabolic disease/disorder involving immune mechanism, 0–64, per 100 000, males
  • SDR, endocrine/nutrition/metabolic disease/disorder involving immune mechanism, all ages, per 100 000, females
  • SDR, endocrine/nutrition/metabolic disease/disorder involving immune mechanism, all ages, per 100 000, males
  • SDR, external causes of injury and poisoning, 0–4
  • SDR, external causes of injury and poisoning, 0–4, females
  • SDR, external causes of injury and poisoning, 0–4, males
  • SDR, external causes of injury and poisoning, 0–64, per 100 000
  • SDR, external causes of injury and poisoning, 0–64, per 100 000, females
  • SDR, external causes of injury and poisoning, 0–64, per 100 000, males
  • SDR, external causes of injury and poisoning, 5–19
  • SDR, external causes of injury and poisoning, 5–19, females
  • SDR, external causes of injury and poisoning, 5–19, males
  • SDR, external causes of injury and poisoning, 65+, per 100 000
  • SDR, external causes of injury and poisoning, 65+, per 100 000, females
  • SDR, external causes of injury and poisoning, 65+, per 100 000, males
  • SDR, external causes of injury and poisoning, all ages, per 100 000
  • SDR, external causes of injury and poisoning, all ages, per 100 000, females
  • SDR, external causes of injury and poisoning, all ages, per 100 000, males
  • SDR, homicide and intentional injury, 0–64, per 100 000
  • SDR, homicide and intentional injury, 0–64, per 100 000, females
  • SDR, homicide and intentional injury, 0–64, per 100 000, males
  • SDR, homicide and intentional injury, 65+, per 100 000
  • SDR, homicide and intentional injury, 65+, per 100 000, females
  • SDR, homicide and intentional injury, 65+, per 100 000, males
  • SDR, homicide and intentional injury, all ages, per 100 000
  • SDR, homicide and intentional injury, all ages, per 100 000, females
  • SDR, homicide and intentional injury, all ages, per 100 000, males
  • SDR, infectious and parasitic diseases, 0–64, per 100 000
  • SDR, infectious and parasitic diseases, 0–64, per 100 000, females
  • SDR, infectious and parasitic diseases, 0–64, per 100 000, males
  • SDR, infectious and parasitic diseases, 65+, per 100 000
  • SDR, infectious and parasitic diseases, 65+, per 100 000, females
  • SDR, infectious and parasitic diseases, 65+, per 100 000, males
  • SDR, infectious and parasitic diseases, all ages, per 100 000
  • SDR, infectious and parasitic diseases, all ages, per 100 000, females
  • SDR, infectious and parasitic diseases, all ages, per 100 000, males
  • SDR, ischaemic heart disease, 0–64, per 100 000
  • SDR, ischaemic heart disease, 0–64, per 100 000, females
  • SDR, ischaemic heart disease, 0–64, per 100 000, males
  • SDR, ischaemic heart disease, 65+, per 100 000
  • SDR, ischaemic heart disease, 65+, per 100 000, females
  • SDR, ischaemic heart disease, 65+, per 100 000, males
  • SDR, ischaemic heart disease, all ages, per 100 000
  • SDR, ischaemic heart disease, all ages, per 100 000, females
  • SDR, ischaemic heart disease, all ages, per 100 000, males
  • SDR, major non-communicable diseases, 30-69 years, both sexes
  • SDR, major noncommunicable diseases, 30-69 years, females
  • SDR, major noncommunicable diseases, 30-69 years, males
  • SDR, malignant neoplasm female breast, 0–64, per 100 000
  • SDR, malignant neoplasm female breast, 65+, per 100 000
  • SDR, malignant neoplasm female breast, all ages, per 100 000
  • SDR, malignant neoplasms, 0–64, per 100 000
  • SDR, malignant neoplasms, 0–64, per 100 000, females
  • SDR, malignant neoplasms, 0–64, per 100 000, males
  • SDR, malignant neoplasms, 65+, per 100 000
  • SDR, malignant neoplasms, 65+, per 100 000, females
  • SDR, malignant neoplasms, 65+, per 100 000, males
  • SDR, malignant neoplasms, all ages, per 100 000
  • SDR, malignant neoplasms, all ages, per 100 000, females
  • SDR, malignant neoplasms, all ages, per 100 000, males
  • SDR, mental disorders, diseases of nervous system and sense organs, 0–64, per 100 000
  • SDR, mental disorders, diseases of nervous system and sense organs, 0–64, per 100 000, females
  • SDR, mental disorders, diseases of nervous system and sense organs, 0–64, per 100 000, males
  • SDR, mental disorders, diseases of nervous system and sense organs, 65+/100 000
  • SDR, mental disorders, diseases of nervous system and sense organs, 65+/100 000, females
  • SDR, mental disorders, diseases of nervous system and sense organs, 65+/100 000, males
  • SDR, mental disorders, diseases of nervous system and sense organs, all ages, per 100 000
  • SDR, mental disorders, diseases of nervous system and sense organs, all ages, per 100 000, females
  • SDR, mental disorders, diseases of nervous system and sense organs, all ages, per 100 000, males
  • SDR, motor vehicle traffic accidents, 0–64, per 100 000
  • SDR, motor vehicle traffic accidents, 0–64, per 100 000, females
  • SDR, motor vehicle traffic accidents, 0–64, per 100 000, males
  • SDR, motor vehicle traffic accidents, 65+, per 100 000, females
  • SDR, motor vehicle traffic accidents, 65+, per 100 000, males
  • SDR, motor vehicle traffic accidents, 65+, per 100 0000
  • SDR, motor vehicle traffic accidents, all ages, per 100 000
  • SDR, motor vehicle traffic accidents, all ages, per 100 000, females
  • SDR, motor vehicle traffic accidents, all ages, per 100 000, males
  • SDR, selected alcohol-related causes, per 100 000
  • SDR, selected alcohol-related causes, per 100 000, females
  • SDR, selected alcohol-related causes, per 100 000, males
  • SDR, selected smoking-related causes, per 100 000
  • SDR, selected smoking-related causes, per 100 000, females
  • SDR, selected smoking-related causes, per 100 000, males
  • SDR, suicide and self-inflicted injury, 0–64, per 100 000
  • SDR, suicide and self-inflicted injury, 0–64, per 100 000, females
  • SDR, suicide and self-inflicted injury, 0–64, per 100 000, males
  • SDR, suicide and self-inflicted injury, 65+, per 100 000
  • SDR, suicide and self-inflicted injury, 65+, per 100 000, females
  • SDR, suicide and self-inflicted injury, 65+, per 100 000, males
  • SDR, suicide and self-inflicted injury, all ages, per 100 000
  • SDR, suicide and self-inflicted injury, all ages, per 100 000, females
  • SDR, suicide and self-inflicted injury, all ages, per 100 000, males
  • SDR, symptoms, signs and ill defined conditions, 0–64, per 100 000
  • SDR, symptoms, signs and ill defined conditions, 0–64, per 100 000, females
  • SDR, symptoms, signs and ill defined conditions, 0–64, per 100 000, males
  • SDR, symptoms, signs and ill defined conditions, 65+, per 100 000
  • SDR, symptoms, signs and ill defined conditions, 65+, per 100 000, females
  • SDR, symptoms, signs and ill defined conditions, 65+, per 100 000, males
  • SDR, symptoms, signs and ill defined conditions, all ages, per 100 000, females
  • SDR, symptoms, signs and ill defined conditions, all ages, per 100 000, males
  • SDR, symptoms, signs and ill-defined conditions, all ages, per 100 000
  • SDR, trachea/bronchus/lung cancer, 0–64, per 100 000
  • SDR, trachea/bronchus/lung cancer, 0–64, per 100 000, females
  • SDR, trachea/bronchus/lung cancer, 0–64, per 100 000, males
  • SDR, trachea/bronchus/lung cancer, 65+, per 100 000
  • SDR, trachea/bronchus/lung cancer, 65+, per 100 000, females
  • SDR, trachea/bronchus/lung cancer, 65+, per 100 000, males
  • SDR, trachea/bronchus/lung cancer, all ages, per 100 000
  • SDR, trachea/bronchus/lung cancer, all ages, per 100 000, females
  • SDR, trachea/bronchus/lung cancer, all ages, per 100 000, males
  • SDR, transport accidents, all ages, per 100 000
  • SDR, transport accidents, all ages, per 100 000, females
  • SDR, transport accidents, all ages, per 100 000, males
  • SDR, tuberculosis, all ages, per 100 000
  • SDR, tuberculosis, all ages, per 100 000, females
  • SDR, tuberculosis, all ages, per 100 000, males
  • Deaths from unintentional injuries by cause in the age group 0–19 years
  • Standardized death rates for unintentional injuries in the age group 1–19 years - drowning and submersion
  • Standardized death rates unintentional injuries in the age group 1–19 years - accidental falls
  • Standardized death rates unintentional injuries in the age group 1–19 years - exposure to smoke, fire and flames
  • Standardized death rates unintentional injuries in the age group 1–19 years - poisoning
  • Prevalence of overweight (including obesity) among 11-year-olds
  • Prevalence of overweight (including obesity) among 13-year-olds
  • Prevalence of overweight (including obesity) among 15-year-olds
  • Percentages of physically active children among 11-year-olds
  • Percentages of physically active children among 13-year-olds
  • Percentages of physically active children among 15-year-olds
  • Post-neonatal infant death rates due to respiratory diseases
  • Percentage of people living in cities with various PM10 levels in μg/m3
  • Percentage of people living in cities with various PM2.5 levels in μg/m3
  • Population weighted annual mean PM10 in cities
  • Population weighted annual mean PM2.5 in cities
  • Proportion of 11-year-old children smoking daily
  • Proportion of 13-year-old children smoking daily
  • Proportion of 13–15-year-olds exposed to SHS inside and outside the home
  • Proportion of 15-year-old children smoking daily
  • Proportion of population in relative poverty living in homes with self-reported problems of damp
  • Proportion of the total population living in homes with self-reported problems of damp
  • Percentages of children aged 0−14 years living in homes using solid fuels for cooking
  • Degree of implementation of policies to reduce exposure of children to SHS
  • Proportion of countries implementing policies to re-duce exposure of children to SHS
  • Percentage of people living in cities with various SOMO35 levels
  • Population weighted annual mean SOMO35 in cities
  • Absenteeism from work due to illness, days per employee per year
  • Age-standardized prevalence of current tobacco smoking among people aged 15 years and over, WHO estimates (%)
  • Age-standardized prevalence of current tobacco smoking among people aged 15 years and over, WHO estimates (%), females
  • Age-standardized prevalence of current tobacco smoking among people aged 15 years and over, WHO estimates (%), males
  • Age-standardized prevalence of obesity (defined as BMI = 30 kg/m2) in people aged 18 years and over, WHO estimates (%)
  • Age-standardized prevalence of obesity (defined as BMI = 30 kg/m2) in people aged 18 years and over, WHO estimates (%), females
  • Age-standardized prevalence of obesity (defined as BMI = 30 kg/m2) in people aged 18 years and over, WHO estimates (%), males
  • Age-standardized prevalence of overweight (defined as BMI = 25 kg/m2) in people aged 18 years and over, WHO estimates (%)
  • Age-standardized prevalence of overweight (defined as BMI = 25 kg/m2) in people aged 18 years and over, WHO estimates (%), females
  • Age-standardized prevalence of overweight (defined as BMI = 25 kg/m2) in people aged 18 years and over, WHO estimates (%), males
  • All cases of mental disorders at year's end
  • Estimated incidence of tuberculosis per 100 000
  • Estimated mortality of tuberculosis per 100 000
  • Estimated prevalence of tuberculosis per 100 000
  • Hospital discharges, all neoplasms
  • Hospital discharges, all neoplasms per 100 000
  • Hospital discharges, cerebrovascular diseases
  • Hospital discharges, cerebrovascular diseases, per 100 000
  • Hospital discharges, circulatory system disease, per 100 000
  • Hospital discharges, digestive system diseases
  • Hospital discharges, digestive system diseases, per 100 000
  • Hospital discharges, infectious and parasitic diseases
  • Hospital discharges, infectious and parasitic diseases per 100 000
  • Hospital discharges, injury and poisoning
  • Hospital discharges, injury and poisoning, per 100 000
  • Hospital discharges, ischaemic heart disease, per 100 000
  • Hospital discharges, mental and behavioural disorders, per 100 000
  • Hospital discharges, musculoskeletal system and connective tissue diseases
  • Hospital discharges, musculoskeletal system and connective tissue diseases, per 100 000
  • Hospital discharges, respiratory system diseases
  • Hospital discharges, respiratory system diseases, per 100 000
  • Incidence of acute poliomyelitis per 100 000
  • Incidence of alcoholic psychosis per 100 000
  • Incidence of cancer per 100 000
  • Incidence of cancer per 100 000, female
  • Incidence of cancer per 100 000, males
  • Incidence of cervix uteri cancer per 100 000
  • Incidence of congenital rubella per 100 000
  • Incidence of congenital syphilis per 100 000
  • Incidence of diphtheria per 100 000
  • Incidence of female breast cancer per 100 000
  • Incidence of gonococcal infection per 100 000
  • Incidence of Haemophilus influenzae type b invasive disease per 100 000
  • Incidence of hepatitis C per 100 000
  • Incidence of malaria per 100 000
  • Incidence of measles per 100 000
  • Incidence of mental disorders per 100 000
  • Incidence of mumps per 100 000
  • Incidence of neonatal tetanus per 100 000
  • Incidence of pertussis per 100 000
  • Incidence of rubella per 100 000
  • Incidence of syphilis per 100 000
  • Incidence of tetanus per 100 000
  • Incidence of trachea, bronchus and lung cancer per 100 000
  • Incidence of trachea, bronchus and lung cancer per 100 000, females
  • Incidence of trachea, bronchus and lung cancer per 100 000, males
  • Incidence of tuberculosis per 100 000
  • Incidence of viral hepatitis A per 100 000
  • Incidence of viral hepatitis B per 100 000
  • Incidence of viral hepatitis per 100 000
  • New cases, diabetes mellitus per 100 000
  • New invalidity/disability cases per 100 000
  • Number cigarettes consumed per person per year
  • Number of all cases cancer at year's end, females
  • Number of all cases cancer at year's end, males
  • Number of all cases of cancer at year's end
  • Number of all cases of diabetes mellitus at year's end
  • Number of cases of chronic obstructive pulmonary disease
  • Number of deaths from malaria
  • Number of hospital discharges, circulatory system disease
  • Number of hospital discharges, ischaemic heart disease
  • Number of hospital discharges, mental and behavioural disorders
  • Number of mental patients staying in hospitals 365+ days
  • Number of mental patients staying in hospitals 365+ days per 100 000
  • Number of new AIDS cases
  • Number of new cases of alcoholic psychosis
  • Number of new cases of cancer
  • Number of new cases of cancer, females
  • Number of new cases of cancer, males
  • Number of new cases of cervix uteri cancer
  • Number of new cases of diabetes mellitus
  • Number of new cases of female breast cancer
  • Number of new cases of mental disorders
  • Number of new cases of trachea, bronchus and lung cancer
  • Number of new cases of trachea, bronchus and lung cancer, females
  • Number of new cases of trachea, bronchus and lung cancer, males
  • Number of new congenital rubella cases
  • Number of new congenital syphilis cases
  • Number of new diphtheria cases
  • Number of new gonococcal infection cases
  • Number of new Haemophilus influenzae type b invasive disease cases
  • Number of new hepatitis A cases
  • Number of new hepatitis B cases
  • Number of new hepatitis C cases
  • Number of new HIV diagnoses
  • Number of new malaria cases
  • Number of new measles cases
  • Number of new mumps cases
  • Number of new neonatal tetanus cases
  • Number of new pertussis cases
  • Number of new poliomyelitis cases
  • Number of new rubella cases
  • Number of new syphilis cases
  • Number of new tetanus cases
  • Number of new tuberculosis cases
  • Number of new viral hepatitis cases
  • Number of newly recognized invalidity/disability cases
  • Number of people receiving social/disability benefits
  • People receiving social/disability benefits per 100 000
  • Prevalence of cancer (%)
  • Prevalence of cancer (%), females
  • Prevalence of cancer (%), males
  • Prevalence of chronic obstructive pulmonary disease (%)
  • Prevalence of diabetes mellitus (%)
  • Prevalence of mental disorders (%)
  • Proportion (%) of tuberculosis cases cured under DOTS
  • Proportion (%) of tuberculosis cases detected under DOTS
  • Rate of new AIDS cases per 100 000
  • Rate of new HIV diagnoses per 100 000
  • Total number of cigarettes consumed (in million pieces), per year
  • % of disabled people of working age engaged in regular occupational activity
  • % population self-assessing health as good
  • % population self-assessing health as good, females
  • % population self-assessing health as good, males
  • Estimates of age-standardized incidence of leukaemia in children aged under 15 years
  • Age-standardized incidence of melanoma in people aged under 55 years
  • Time trends of melanoma incidence in Norway, Sweden and Iceland
  • Dioxin levels in human milk in selected countries
  • Level of DDT pollutant concentration in human milk
  • Level of HCB pollutant concentration in human milk
  • Level of PBDE pollutant concentration in human milk
  • Level of PCB pollutant concentration in human milk
  • Level of PCN pollutant concentration in human milk
  • Level of total concentrations for pollutants in human milk expressed in WHO toxic equivalents (WHO-TEQs)
  • POPs levels in human milk, Sweden
  • Heavy metal intake through food by adults
  • Mean level of selected hazardous metals in the total diet of the general population of the Czech Republic
  • Mean blood lead levels of children measured in areas without significant local sources of lead exposure
  • Estimated mean radon levels in dwellings
  • Estimated proportion of dwellings with radon levels ≥200 Bq/m3
  • Estimated proportion of dwellings with radon levels ≥400 Bq/m3
  • Standardized incidence of work injuries among employees aged 18-24 years
  • Standardized incidence of work injuries among employees aged under 18 years
  • Percentage of population reporting that noise is a problem in the living environment
  • Percentage of urban population exposed to noise level Lden > 55 dB
  • Percentage of urban population exposed to noise level Lnight > 50 dB
  • Catastrophic health spending, all households
  • Catastrophic health spending, fourth quintile
  • Catastrophic health spending, poorest quintile
  • Catastrophic health spending, richest quintile
  • Catastrophic health spending, second quintile
  • Catastrophic health spending, third quintile
  • Households further impoverished after out-of-pocket payments
  • Households impoverished after out-of-pocket payments
  • Impoverishing health spending
  • Immigrant population
  • People at risk of poverty or social exclusion
  • Population aged 0–14 years
  • Average amount of cereal available per person per year (kg)
  • Average amount of fruits and vegetables available per person per year (kg)
  • Average number of calories available per person per day (kcal)
  • Beer consumed in pure alcohol, litres per capita, age 15+
  • Fat available per person per day (g)
  • First admissions to drug treatment centres per 100 000
  • Number of first admissions to drug treatment centres
  • Number of people killed or injured in road traffic accidents
  • Number of road traffic accidents involving alcohol
  • Number of road traffic accidents with injury
  • People killed or injured in road traffic accidents per 100 000
  • Protein available per person per day (g)
  • Road traffic accidents involving alcohol per 100 000
  • Road traffic accidents with injury per 100 000
  • Spirits consumed in pure alcohol, litres per capita, age 15+
  • Wine consumed in pure alcohol, litres per capita, age 15+
  • % of regular daily smokers in the population, age 15+
  • % of regular daily smokers in the population, age 15+, females
  • % of regular daily smokers in the population, age 15+, males
  • % of total energy available from fat
  • % of total energy available from protein
  • General paediatricians, per 100 000 population
  • Generalist medical practitioners, per 100 000 population
  • Practicing nurses, per 100 000 population
  • Minimum age of criminal responsibility
  • Potential criminal liability for children
  • Public places included in national smoke-free legislation
  • Brushing Teeth (11, 13, 15 years)
  • Moderate to vigorous physical activity
  • Overweight and obese (11, 13, 15 years)
  • Overweight and obese (6-9 years old)
  • Soft drink consumption (11, 13, 15 years)
  • Condom use at last intercourse (15 years old)
  • Adolescent HIV rates (15-24 years)
  • Estimated child HIV rates
  • HPV vaccine coverage
  • ORT for diarrhoea with continued feeding, children under 5
  • PCV vaccine coverage
  • Rotavirus vaccine coverage
  • Tuberculosis reported cases in children
  • Tuberculosis, lab-confirmed cases in children
  • Tuberculosis, new cases in children
  • Ability to buy cigarettes in store (13-15 years)
  • Alcohol consumption (15 years)
  • Being bullied (11, 13, 15 years)
  • Bullying others (11, 13, 15 years)
  • Child Homicide (0-14 years)
  • Fighting (11, 13, 15 years)
  • Lifetime cannabis use (15 years)
  • Lifetime drunkenness (11, 13, 15 years)
  • Medically attended Injuries (15 years)
  • Smoke exposure (13 - 15 years)
  • Weekly smoking (11, 13, 15 years)
  • Child suicide (0-14 years old)
  • Classmate support (11, 13, 15 years)
  • Life satisfaction (11, 13, 15 years)
  • Being bullied (11, 13, 15 years), by family affluence quintile
  • Brushing Teeth (11, 13, 15 years), by family affluence quintile
  • Bullying others (11, 13, 15 years), by family affluence quintile
  • Moderate-to-vigorous physical activity (11, 13, 15 years), by family affluence quintile
  • Smoking (11, 13, 15 years), by family affluence quintile
  • Soft drink consumption (11, 13, 15 years), by family affluence quintile
  • Influenza vaccination coverage, elderly
  • Influenza vaccination recommendation, elderly
  • Influenza vaccination coverage, pregnant women
  • Influenza vaccination recommendation, pregnant women
  • Average number of people per room in occupied housing unit
  • Deaths due to work-related accidents per 100 000
  • Microbiological foodborne diseases per 100 000
  • Microbiological foodborne diseases, number of outbreaks
  • New cases of occupational diseases per 100 000
  • Number of cases of microbiological foodborne diseases
  • Number of deaths due to work-related accidents
  • Number of new cases of occupational diseases
  • Number of people injured due to work-related accidents
  • Number of salmonellosis cases
  • People injured due to work-related accidents per 100 000
  • Salmonellosis cases per 100 000
  • % population with access to sewage system, septic tank or other hygienic means of sewage disposal
  • % population with access to sewage system, septic tank or other hygienic means of sewage disposal, rural
  • % population with access to sewage system, septic tank or other hygienic means of sewage disposal, urban
  • % population with homes connected to water supply system
  • % population with homes connected to water supply system, rural
  • % population with homes connected to water supply system, urban
  • Influenza vaccination coverage, health care workers
  • Influenza vaccination recommendation, health care workers
  • Influenza vaccination coverage, long term care facilities
  • Influenza vaccination recommendation, long term care facilities
  • Influenza vaccination coverage, children first age-group
  • Influenza vaccination coverage, children second age-group
  • Influenza vaccination recommendation, children
  • Influenza vaccination coverage, chronic diseases
  • Influenza vaccination recommendation, chronic diseases
  • Breakfast with family
  • Difference in drinking soft-drinks, by FAS
  • Difference in eating fruit, by FAS
  • Difference in having family meals, by FAS
  • Differences in eating breakfast weekend, by FAS
  • Differences in eating sweets, by FAS
  • Differences in eating vegetables, by FAS
  • Differences in family meals together, by FAS
  • Drinking soft-drinks
  • Eating breakfast
  • Eating breakfast weekend
  • Eating breakfast, by FAS
  • Eating fruit
  • Eating sweets
  • Eating vegetables
  • Family meals together
  • Having family meals
  • Brushing teeth
  • Difference in brushing teeth, by FAS
  • Computer games
  • Difference in moderate-to-vigorous physical activity, by FAS
  • Differences in television watching, by FAS
  • Differences in vigorous physical activity by FAS
  • Moderate-to-vigorous physical activity
  • Screen time
  • Vigorous physical activity
  • Vigorous physical activity (timeexe)
  • Watching television
  • BMI
  • BMI (missing)
  • Body image
  • Differences in bmi, by FAS
  • Differences in body image, by FAS
  • Differences in overweight and obese (IOTF), by FAS
  • Differences in thin (IOTF), by FAS
  • Differences in weight-reduction behaviour, by FAS
  • Overweight and obese
  • Thin (IOTF)
  • Weight-reduction behaviour
  • Backache
  • Differences in backache, by FAS
  • Differences in difficulties in getting to sleep, by FAS
  • Differences in feeling dizzy, by FAS
  • Differences in feeling low, by FAS
  • Differences in feeling nervous, by FAS
  • Differences in headache, by FAS
  • Differences in health complaints, by FAS
  • Differences in irritable or bad temper, by FAS
  • Differences in life satisfaction, by FAS
  • Differences in self-rated health, by FAS
  • Differences in stomach ache, by FAS
  • Difficulties sleeping
  • Feeling dizzy
  • Feeling low
  • Feeling nervous
  • Headache
  • Health complaints
  • Irritable or bad temper
  • Life satisfaction
  • Self-rated health
  • Stomach ache
  • Differences in medically attended injuries, by FAS
  • Medically attended injuries
  • Severe injury
  • Acute (short-stay) hospitals per 100 000
  • Acute care hospital beds per 100 000
  • Acute care hospital beds, medical group of specialties
  • Acute care hospital beds, medical group of specialties, per 100 000
  • Acute care hospital beds, obstetric and gynaecological group of specialties
  • Acute care hospital beds, obstetric and gynaecological group of specialties, per 100 000
  • Acute care hospital beds, paediatric group of specialties
  • Acute care hospital beds, paediatric group of specialties, per 100 000
  • Acute care hospital beds, surgical group of specialties
  • Acute care hospital beds, surgical group of specialties, per 100 000
  • Dentists (FTE) per 100 000
  • Dentists (PP) per 100 000
  • Dentists graduated per 100 000
  • General practitioners (PP) per 100 000
  • Hospital beds per 100 000
  • Hospitals per 100 000
  • Midwives (FTE) per 100 000
  • Midwives (PP) per 100 000
  • Midwives graduated per 100 000
  • Number of acute (short-stay) hospitals
  • Number of acute care hospital beds
  • Number of dentists (FTE)
  • Number of dentists (PP)
  • Number of dentists graduated in given year
  • Number of general practitioners (PP)
  • Number of hospitals
  • Number of midwives (FTE)
  • Number of midwives (PP)
  • Number of midwives graduated in given year
  • Number of nurses (FTE)
  • Number of nurses (PP)
  • Number of nurses graduated in given year
  • Number of nursing and elderly home beds
  • Number of pharmacists (PP)
  • Number of pharmacists graduated in given year
  • Number of physicians graduated in given year
  • Number of physicians, full-time equivalent (FTE)
  • Number of physicians, medical group of specialties (PP)
  • Number of physicians, obstetric and gynaecological group of specialties (PP)
  • Number of physicians, paediatric specialties (PP)
  • Number of physicians, physical persons (PP)
  • Number of physicians, surgical group of specialties (PP)
  • Number of primary health care units
  • Number of private inpatient hospital beds
  • Number of psychiatric hospital beds
  • Nurses (FTE) per 100 000
  • Nurses (PP) per 100 000
  • Nurses graduated per 100 000
  • Nursing and elderly home beds per 100 000
  • Pharmacists (PP) per 100 000
  • Pharmacists graduated per 100 000
  • Physicians graduated per 100 000
  • Physicians per 100 000
  • Physicians, full-time equivalent (FTE) per 100 000
  • Physicians, medical group of specialties (PP), per 100 000
  • Physicians, obstetric and gynaecological group of specialties (PP), per 100 000
  • Physicians, paediatric group of specialties (PP), per 100 000
  • Physicians, surgical group of specialties (PP), per 100 000
  • Primary health care units per 100 000
  • Private inpatient hospital beds as % of all beds
  • Psychiatric hospital beds per 100 000
  • Total number of hospital beds
  • % of nurses working in hospitals
  • % of physicians working in hospitals
  • Differences in ever smoked in lifetime, by FAS
  • Differences in smoked cigarettes in the last 30d, by FAS
  • Differences in smoking initiation, by FAS
  • Differences in smoking, by FAS
  • Ever smoked
  • Smoked cigarettes in the last 30d
  • Smoking
  • Smoking daily
  • Smoking initiation
  • Alcohol consumption
  • Alcohol initiation
  • Differences in alcohol consumption, by FAS
  • Differences in drunk alcohol in lifetime, by FAS
  • Differences in drunk alcohol last 30d, by FAS
  • Differences in drunkenness initiation, by FAS
  • Differences in drunkenness, by FAS
  • Drinking alcopops
  • Drinking beer
  • Drinking spirits
  • Drinking wine
  • Drunk alcohol in lifetime
  • Drunk alcohol last 30d
  • Drunkenness
  • Drunkenness initiation
  • Cannabis initiation
  • Cannabis use last 30 days
  • Cannabis use lifetime
  • Differences in cannabis initiation, by FAS
  • Differences in cannabis use last 30 days, by FAS
  • Differences in cannabis use lifetime, by FAS
  • Differences in physical fighting ≥3, by FAS
  • Physical fighting ≥3
  • Physical fighting once
  • Been bullied once or twice
  • Been cyber bullied once or more
  • Being bullied
  • Bullied others once
  • Bullying others
  • Cyber bullied others once or more
  • Cyber-bullied mean message
  • Cyber-bullied with picture
  • Cyber-bullied with picture several times
  • Cyber-bullying
  • Differences in been cyber bullied once or more, by FAS
  • Differences in being bullied, by FAS
  • Differences in bullied others once or more, by FAS
  • Differences in bullying others, by FAS
  • Differences in cyber bullied others once or more, by FAS
  • Differences in cyber-bullying, by FAS
  • Differences in physical fighting once or more, by FAS
  • Birth control pill use
  • Condom use
  • Differences in condom use, by FAS
  • Differences in sexual intercourse, by FAS
  • Sexual intercourse
  • Differences in family support, by FAS
  • Differences in talk to father, by FAS
  • Differences in talk to mother, by FAS
  • Family communication
  • Family structure
  • Family support
  • Immigrant status
  • Mean FAS index score
  • Talk to father
  • Talk to mother
  • Differences in intensive online contact, by FAS
  • Differences in meeting friends before 8 pm, by FAS
  • Differences in peer support, by FAS
  • Differences in preference for online communication, by FAS
  • Differences in problematic social media users, by FAS
  • Differences in social media contact, by FAS
  • Intensive online contact
  • Meet friends after 8 pm
  • Meet friends before 8 pm
  • Peer support
  • Preference for online communication
  • Problematic social media users
  • Social media contact
  • Texting with friends
  • Classmate support
  • Classmate support
  • Differences in classmate support, by FAS
  • Differences in classmate support, by FAS
  • Differences in liking school, by FAS
  • Differences in pressured by schoolwork, by FAS
  • Differences in school performance, by FAS
  • Differences in teacher support, by FAS
  • Liking school
  • Pressured by schoolwork
  • School performance
  • Teacher support
  • Dietary recommendations for at-risk groups
  • Implementation of recommendations on nutrition
  • Nutrition counselling for at-risk groups
  • Professionals delivering recommendations on nutrition during postpartum
  • Professionals delivering recommendations on nutrition during pregnancy
  • Professionals receiving training on nutrition during postpartum
  • Professionals receiving training on nutrition during pregnancy
  • Recommendations on energy and nutrient intakes for postpartum women
  • Recommendations on energy and nutrient intakes for pregnant and lactating women
  • Recommendations on nutrition for women of reproductive age
  • Review of recommendations on nutrition
  • Training for professionals on nutritional recommendations
  • Training for professionals on nutritional recommendations during pregnancy and the postpartum
  • Acute care hospital discharges per 100
  • Autopsy rate (%) for all deaths
  • Autopsy rate (%) for hospital deaths
  • Average length of stay, acute care hospitals only
  • Average length of stay, all hospitals
  • Bed occupancy rate (%), acute care hospitals only
  • Inpatient care discharges per 100
  • Inpatient surgical procedures per year per 100 000
  • Number of acute care hospital discharges
  • Number of all hospital discharges
  • Outpatient contacts per person per year
  • Private households' out-of-pocket payments on health as % of private-sector health expenditure
  • Private households' out-of-pocket payments on health as % of total health expenditure
  • Private-sector expenditure on health as % of GDP, WHO estimates
  • Private-sector expenditure on health as % of total health expenditure, WHO estimates
  • Public expenditure on health, PPP$ per capita, WHO estimates
  • Public inpatient expenditure as % of total inpatient expenditure
  • Public pharmaceutical expenditure as % of total pharmaceutical expenditure
  • Public-sector expenditure on health as % of GDP, WHO estimates
  • Public-sector expenditure on health as % of total government expenditure, WHO estimates
  • Public-sector health expenditure as % of total health expenditure
  • Public-sector health expenditure as % of total health expenditure, WHO estimates
  • Salaries as % of total public health expenditure
  • SDR, adverse effects of therapeutic agents, 0–64, per 100 000
  • SDR, adverse effects of therapeutic agents, 0–64, per 100 000, females
  • SDR, adverse effects of therapeutic agents, 0–64, per 100 000, males
  • SDR, adverse effects of therapeutic agents, all ages, per 100 000
  • SDR, adverse effects of therapeutic agents, all ages, per 100 000, females
  • SDR, adverse effects of therapeutic agents, all ages, per 100 000, males
  • SDR, appendicitis, 0–64, per 100 000
  • SDR, appendicitis, 0–64, per 100 000, females
  • SDR, appendicitis, 0–64, per 100 000, males
  • SDR, appendicitis, all ages, per 100 000
  • SDR, appendicitis, all ages, per 100 000, females
  • SDR, appendicitis, all ages, per 100 000, males
  • SDR, hernia and intestinal obstruction, 0–64, per 100 000
  • SDR, hernia and intestinal obstruction, 0–64, per 100 000, females
  • SDR, hernia and intestinal obstruction, 0–64, per 100 000, males
  • SDR, hernia and intestinal obstruction, all ages, per 100 000
  • SDR, hernia and intestinal obstruction, all ages, per 100 000, females
  • SDR, hernia and intestinal obstruction, all ages, per 100 000, males
  • Surgical wound infection rate (%), all operations
  • Total capital investment expenditure on medical facilities as % of total health expenditure
  • Total health expenditure as % of GDP
  • Total health expenditure as % of GDP, WHO estimates
  • Total health expenditure, PPP$ per capita
  • Total health expenditure, PPP$ per capita, WHO estimates
  • Total inpatient expenditure as % of total health expenditure
  • Total number of inpatient surgical procedures per year
  • Total pharmaceutical expenditure as % of total health expenditure
  • Implementation of recommendations on physical activity
  • Physical activity counselling for at-risk groups
  • Physical activity recommendations for at-risk groups
  • Recommendations on physical activity for women during/after pregnancy
  • Recommendations on physical activity for women of reproductive age
  • Review of recommendations on physical activity
  • Cut-off for BMI according to WHO standards
  • Development and implementation of the recommendations on weight gain during pregnancy
  • Guidance on frequency of weight recording during pregnancy
  • Professionals responsible for recording and monitoring weight during pregnancy
  • Recommendations based on pre-pregnancy BMI
  • Recommendations on weight gain during pregnancy
  • Recommendations on weight gain include guidance for each obese class
  • Baby Friendly Hospital Initiative
  • Implementation of recommendations on newborn, infant and young child nutrition
  • Incorporation of the International Code of Marketing of Breast-milk Substitutes
  • Integrated Management of Childhood Illness
  • International code of marketing of breast-milk substitutes incorporated into national legislation
  • Nationally available recommendations on newborn, infant and young child nutrition
  • Paid maternity leave implemented according to law
  • Parental leave
  • Prevention of obesity on newborn, infant and young child nutrition
  • Prevention of undernutrition on newborn, infant and young child nutrition
  • Professionals delivering recommendations on newborn, infant and young child nutrition
  • Professionals receiving training in recommendations on newborn, infant and young child nutrition
  • Recommendations on newborn, infant and young child nutrition
  • Recommended micronutrient intakes for infants and young children
  • Training of professionals related to recommendations on newborn, infant and young child nutrition
  • Counselling against excessive weight gain during pregnancy
  • Counselling against poor weight gain during pregnancy
  • Obesity prevention during the postpartum period
  • Obesity prevention during the preconception period
  • Recommendations on maternal and child healthcare services for obesity
  • Areas in which support on guidelines implementation was requested
  • Areas in which support on guidelines was requested
  • AMR action plan
  • AMR action plan funds
  • AMR action plan implementation
  • AMR focal point appointed
  • Enrolled in GLASS
  • Implementation of action plan monitored
  • Intersectoral coordinating mechanism
  • AMR reference laboratory nominated
  • AMR surveillance
  • AMR surveillance network meetings
  • AMR surveillance team
  • CAESAR external quality assessment
  • CAESAR reporting
  • Coordination AMR surveillance
  • Functional AMR reference laboratory
  • Laboratory quality assessment system
  • Periodic surveillance reports
  • Carbapenem-resistant Escherichia coli
  • Carbapenem-resistant Klebsiella pneumoniae
  • Methicillin-resistant Staphylococcus aureus (MRSA)
  • Multidrug-resistant Acinetobacter spp.
  • Multidrug-resistant Klebsiella pneumoniae
  • Third-generation cephalosporin-resistant Escherichia coli
  • National nutrition policies, strategies and action plans
  • Higher education training in nutrition
  • Trained nutritionists and dieticians working in nutrition-related areas in government or non-government sectors
  • Abortions per 1000 live births
  • Abortions per 1000 live births, age 35+ years
  • Abortions per 1000 live births, age under 20 years
  • Births with Down's syndrome per 100 000 live births
  • Caesarean sections per 1000 live births
  • Congenital anomalies per 100 000 live births
  • Contraceptive use among currently married women aged 15–49 (%), any method
  • Fetal deaths per 1000 births
  • Infant deaths per 1000 live births
  • Infant deaths per 1000 live births, females
  • Infant deaths per 1000 live births, males
  • Late neonatal deaths per 1000 live births
  • Maternal deaths per 100 000 live births according to clinical data
  • Maternal deaths per 100 000 live births, max of cod and clinical data
  • Maternal deaths, abortion, per 100 000 live births
  • Maternal deaths, cause of death data per 100 000 live births
  • Maternal deaths, gestational (pregnancy-induced) hypertension and hyperemesis, per 100 000 live births
  • Maternal deaths, haemorrhage, per 100 000 live births
  • Maternal deaths, puerperium, per 100 000 live births
  • Neonatal deaths per 1000 live births
  • Number of abortions, age 35+ years
  • Number of abortions, age under 20 years
  • Number of abortions, all ages
  • Number of all live births to mothers aged under 20 years
  • Number of all live births, mothers aged 35+ years
  • Number of births with congenital anomalies
  • Number of births with Down's syndrome
  • Number of caesarean sections
  • Number of dead-born fetuses
  • Number of deadborn fetuses with a birth weight of 1000 g or more
  • Number of early neonatal deaths
  • Number of early neonatal deaths with a birth weight of 1000 g or more
  • Number of live births with a birth weight of 1000 g or more
  • Perinatal deaths 1000+g per 1000 births
  • Perinatal deaths national criteria per 1000 births
  • Perinatal deaths per 1000 births
  • Postneonatal deaths per 1000 live births
  • Proportion (%) of births attended by skilled health personnel
  • % infants vaccinated against invasive disease due to Haemophilus influenzae type b
  • % of all live births to mothers aged 35+ years
  • % of all live births to mothers aged under 20 years
  • % of children vaccinated against measles
  • % of infants breastfed at age 3 months
  • % of infants breastfed at age 6 months
  • % of infants vaccinated against diphtheria
  • % of infants vaccinated against hepatitis B
  • % of infants vaccinated against mumps
  • % of infants vaccinated against pertussis
  • % of infants vaccinated against poliomyelitis
  • % of infants vaccinated against rubella
  • % of infants vaccinated against tetanus
  • % of infants vaccinated against tuberculosis
  • % of live births weighing 2500 g or more
  • Baby-friendly Hospital Initiative (BFHI)
  • Breastfeeding promotion and counselling
  • Complementary feeding counselling or education
  • Components of breastfeeding promotion and counselling
  • Components of counselling or education on complementary feeding
  • Components of growth monitoring and promotion for children under 5
  • Growth monitoring and promotion for children under 5
  • Components of the school health and nutrition policy, programme or standard
  • School health and nutrition policies, programmes and related standards
  • Standards or rules for foods and beverages available in schools
  • National dietary guidelines
  • Nutrition labelling being implemented
  • Nutrition labelling of foods and beverages
  • Reformulation measures for foods and beverages
  • Reformulation measures to reduce the content of specific nutrients
  • Measures to ban or virtually eliminate industrial trans fatty acids
  • Fiscal policies for healthy diets
  • Definitions to restrict marketing of food and non-alcoholic beverages to children
  • Measures to regulate or guide marketing of food and non-alcoholic beverages to children
  • Measures to regulate or guide marketing of food to children in specific communication channels
  • Measures to control portion sizes
  • Media campaigns on healthy diet and nutrition
  • Members of the European Health Information Initiative
  • Nutrition education and counselling in primary health care or other settings
  • Food consumption/nutrient intake surveys
  • Methods used in the food consumption/nutrient intake surveys in the country
  • Nutrients assessed in the food consumption/nutrient intake surveys
  • Available budget allocated by government for CAH Strategy
  • Mechanism for intersectoral planning and implementation of CAH exists
  • National CAH strategy exists
  • Production of annual report on the status of children and adolescents
  • Stand-alone CAH strategy or part of another strategy
  • Strategy review plans before 2020
  • Systems to monitor implementation of CAH strategy exist
  • Available data on gaps between staffing levels for children and adolescent health services
  • Child maltreatment surveys completed by children themselves
  • Child maltreatment surveys completed by institutions
  • Child maltreatment surveys completed by parents
  • Collection of systematic information on the health of migrant and refugee children
  • Data available on number of single, underage migrant or refugee children using social services
  • Data for major interventions disaggregated by ethnic background
  • Data for major interventions disaggregated by migrant status
  • Data for major interventions disaggregated by rural, suburban and specific urban areas
  • Data for major interventions disaggregated by sex
  • Data for major interventions disaggregated by socioeconomic background
  • Frequency of population-based survey on child maltreatment
  • Health statistics available on the health services provided to at-risk groups
  • Information systems exist that separate out services for adolescents
  • Information systems exist that separate out services for children
  • Migrant children only receive care for chronic conditions free of charge
  • Migrant children only receive emergency services free of charge
  • Migrant children only receive preventive services free of charge
  • Migrant children receive all health care services free of charge
  • Rate of children in institutional care per 10 000 population aged 0-17
  • Rate of children in institutional care per 10 000 population aged 0-2
  • Refugee children only receive care for chronic conditions free of charge
  • Refugee children only receive emergency services free of charge
  • Refugee children only receive preventive services free of charge
  • Refugee children receive all health care services free of charge
  • Systematic information on maternal alcohol consumption is collected
  • Surveys on sexual/intimate partner violence with information on young people under 18
  • Consistent national reporting of health under UNCRC
  • Information is collected on children's and adolescent's knowledge regarding sexuality
  • Legal access to abortion without parental consent for adolescents under 18
  • Legal access to contraception without parental consent for adolescents under 18
  • Ombudsman for CAH right to health
  • Ombudsman for children's and adolescent's right
  • Policies for access to care for adolescents without parental consent exist
  • Policies providing guidance for children, adolescents, parents and health workers on consent and confidentiality exist
  • Provision of foster care for institutionalised children
  • Youth involvement in implementation of CAH strategy
  • Adoption of paediatric essential drug list
  • All services are provided to adolescents without pay
  • Available HPV vaccination through national vaccination programmes free of charge
  • Data collection on number of drug prescriptions to children and adolescents under 18
  • Hospitalisation rate for children aged 10-14 years
  • Hospitalisation rate for children aged 15-18 years
  • Hospitalisation rate for children aged 5-9 years
  • Hospitalisation rate for children under 5 years
  • Hospitalisation rate for pneumonia in children under 5 years
  • Legal obligation for perinatal death audits exists
  • Mechanism for assuring quality of care for child and/or adolescents exists
  • Mechanism for continuous training for adolescent health professional exists
  • National policies on transition from paediatric to adult services exist
  • Paediatric formulations available for all essential drugs
  • Publicly available paediatric essential drug list
  • Age and gender appropriate education that addresses sexual/intimate partner violence
  • Coordination of school-based services across government sectors
  • Legislations that affect the availability of unhealthy foods in school exist
  • National school policy includes adolescent mental health
  • National strategy on health promoting schools exists
  • Plans to address unhealthy products in school before 2020
  • Policies for the provision of school health services exist
  • Policy on the provision of sexuality education in schools exists
  • System for supporting Early Childhood Development exists
  • Age of transfer from child to adult mental health services
  • Assessment of quality of mental health services for children and adolescents
  • Community services for early mental health problems are available
  • Guidance for transition from child to adult mental health services
  • Information is collected systematically on the number of children under 18 treated by mental health professional
  • Rate of children treated for ADHD per 100 000 population aged 0-17 years
  • Rate of children treated for Autism per 100 000 population aged 0-17 years
  • Rate of practicing child psychiatrist per 100 000 population aged 0-14 years
  • Rate of practicing child psychologist per 100 000 population aged 0-14 years
  • Rate of prescriptions for mental and behavioural disorders per 10 000 for children and adolescents under 18
  • Data collected on complementary feeding habits for children 6-24 months
  • Data collected on soft drink consumption for children and adolescents
  • Data collected on the marketing of complementary feeding products for children 6-24 months
  • Data collected on the prevalence of overweight/obesity in under 5 children
  • Data on exclusive breastfeeding is collected based on internationally accepted indicators
  • Laws or regulations that restrict marketing to children exist
  • Policy for initiating exclusive breastfeeding exists
  • Minimum age to purchase beer
  • Minimum age to purchase spirits
  • Minimum age to purchase wine
  • Existence of responsible ministry/authority on assistive technology
  • Alcohol consumption
  • Mortality from external causes
  • Mortality from external causes, females
  • Mortality from external causes, males
  • Obesity
  • Obesity, females
  • Obesity, males
  • Overweight
  • Overweight, females
  • Overweight, males
  • Premature mortality
  • Premature mortality, females
  • Premature mortality, males
  • Tobacco smoking
  • Tobacco smoking, females
  • Tobacco smoking, males
  • Infant mortality
  • Infant mortality, females
  • Infant mortality, males
  • Life expectancy
  • Life expectancy, females
  • Life expectancy, males
  • National health inequities policies
  • Life satisfaction
  • Primary school enrolment
  • Primary school enrolment, females
  • Primary school enrolment, males
  • Sanitation
  • Sanitation, rural
  • Sanitation, urban
  • Social support
  • Unemployment
  • Health expenditures
  • Measles vaccination
  • Out-of-pocket expenditures
  • Polio vaccination
  • National accountability mechanisms
  • National implementation plans
  • National policies aligned with Health 2020
  • National target setting
  • Donor/non-public development funding is available for eHealth programmes
  • Institutions or associations offer in-service training in the use of ICT for health as part of the continuing education of health professionals
  • Institutions or associations offer in-service training in the use of social media for health as part of the continuing education of health professionals
  • National eHealth policy or strategy exists
  • National eHealth policy or strategy refers to the objectives or key elements of universal health coverage
  • National health information system policy or strategy exists
  • National policy or strategy on multilingualism exists
  • National policy to govern the use of social media in the health professions exists
  • National universal health coverage policy or strategy exists
  • National universal health coverage policy or strategy refers to the use of information and communication technology (ICT) or eHealth
  • Private or commercial funding is available for eHealth programmes
  • Professional groups that are offered in-service training in social media for health as part of the continuing education of health professionals
  • Professional groups that are offered in-service training in the use of ICT for health as part of the continuing education of health professionals
  • Proportion of funding contribution for eHealth programmes provided by donor/non-public development funding sources over the previous two years
  • Proportion of funding contribution for eHealth programmes provided by private funding sources over the previous two years
  • Proportion of funding contribution for eHealth programmes provided by public funding sources over the previous two years
  • Proportion of funding contribution for eHealth programmes provided by public–private partnership funding sources over the previous two years
  • Proportion of institutions or associations offering in-service training in the use of ICT for health as part of the continuing education of health professionals
  • Proportion of tertiary institutions (public and private) that offer ICT for health (eHealth) courses
  • Proportion of tertiary institutions (public and private) that teach students of health sciences about the use of social media for health
  • Public funding is available for eHealth programmes
  • Public–private partnership funding is available for eHealth programmes
  • Special funding is allocated for the implementation of the national eHealth policy or strategy
  • Tertiary institutions provide training to students of health sciences on the use of ICT for health (eHealth)
  • Tertiary institutions teach students of health sciences about the use of social media for health
  • Access to information and education for health care professionals, using mLearning (operating levels and types of programmes)
  • An entity providing incentives and guidance for innovation, research and evaluation of health apps exists
  • An entity responsible for the regulatory oversight of mobile health apps for quality, safety and reliability exists
  • Government-sponsored mHealth programmes exist
  • mHealth programmes for community mobilization/health promotion campaigns (operating levels and types)
  • mHealth programmes for emergencies (operating levels and types)
  • mHealth programmes for emergency toll-free telephone services (operating levels and types)
  • mHealth programmes for health call centres/health care telephone helpline (operating levels and types)
  • mHealth programmes for health surveys (operating levels and types)
  • mHealth programmes for mobile telehealth (operating levels and types)
  • mHealth programmes for patient monitoring (operating levels and types)
  • mHealth programmes for reminders to attend appointments (operating levels and types)
  • mHealth programmes for surveillance (operating levels and types)
  • mHealth programmes for treatment adherence (operating levels and types)
  • mHealth programmes that provide access to electronic patient information (operating levels and types)
  • mHealth programmes that provide access to information resources, databases and tools (operating levels and types)
  • mHealth programmes that provide clinical decision support (operating levels and types)
  • Policies or strategies that guide mHealth programmes
  • The importance of capacity as a barrier to mHealth supporting universal health coverage
  • The importance of cost–effectiveness as a barrier to mHealth supporting universal health coverage
  • The importance of demand as a barrier to mHealth supporting universal health coverage
  • The importance of effectiveness as a barrier to mHealth supporting universal health coverage
  • The importance of funding as a barrier to mHealth supporting universal health coverage
  • The importance of infrastructure as a barrier to mHealth supporting universal health coverage
  • The importance of legal issues as a barrier to mHealth supporting universal health coverage
  • The importance of policy as a barrier to mHealth supporting universal health coverage
  • The importance of priorities as a barrier to mHealth supporting universal health coverage
  • The role or function of health authorities in respect to the development and adoption of mHealth
  • Dedicated national telehealth policy or strategy exists
  • National telehealth policy or strategy includes objectives that address telehealth's contribution to universal health coverage
  • Remote patient monitoring programmes (operating levels and types)
  • Teledermatology programmes (operating levels and types)
  • Telepathology programmes (operating levels and types)
  • Telepsychiatry programmes (operating levels and types)
  • Teleradiology programmes (operating levels and types)
  • The importance of capacity as a barrier to telehealth supporting universal health coverage
  • The importance of cost–effectiveness as a barrier to telehealth supporting universal health coverage
  • The importance of demand as a barrier to telehealth supporting universal health coverage
  • The importance of effectiveness as a barrier to telehealth supporting universal health coverage
  • The importance of funding as a barrier to telehealth supporting universal health coverage
  • The importance of infrastructure as a barrier to telehealth supporting universal health coverage
  • The importance of legal issues as a barrier to telehealth supporting universal health coverage
  • The importance of policy as a barrier to telehealth supporting universal health coverage
  • The importance of priorities as a barrier to telehealth supporting universal health coverage
  • eLearning courses are accredited by continuing medical education (CME) or professional licensing bodies
  • eLearning is used for the in-service training of health professionals
  • eLearning usage in health sciences teaching institutions
  • eLearning used to help teach health sciences students in pre-service education
  • Main reasons for using eLearning for in-service education
  • Main reasons for using eLearning in pre-service education
  • Professional groups that have adopted eLearning as an approach to in-service training
  • Student groups that are offered eLearning as part of their pre-service education
  • The importance of availability as a barrier to eLearning supporting universal health coverage
  • The importance of capacity as a barrier to eLearning supporting universal health coverage
  • The importance of cost–effectiveness as a barrier to eLearning supporting universal health coverage
  • The importance of demand as a barrier to eLearning supporting universal health coverage
  • The importance of effectiveness as a barrier to eLearning supporting universal health coverage
  • The importance of funding as a barrier to eLearning supporting universal health coverage
  • The importance of infrastructure as a barrier to eLearning supporting universal health coverage
  • The importance of limitation as a barrier to eLearning supporting universal health coverage
  • The importance of policy as a barrier to eLearning supporting universal health coverage
  • The importance of priorities as a barrier to eLearning supporting universal health coverage
  • Universities offer a health sciences degree that can be gained entirely online
  • Universities offer certification in specific health sciences subjects that can be gained entirely online
  • Existence of legislation on access to assistive technology
  • Legislation covering people in need of assistive technology by functional domain
  • Electronic medical billing systems used in the health sector
  • Human resources for health information systems used in the health sector
  • International standards used to support the national EHR system
  • National EHR system exists
  • Specific legislation governing the use of the national electronic health record (EHR) system exists
  • Supply chain management information systems for health used in the health sector
  • Systems linking to national EHR
  • The importance of capacity as a barrier to EHR programmes
  • The importance of cost–effectiveness as a barrier to EHR programmes
  • The importance of demand as a barrier to EHR programmes
  • The importance of effectiveness as a barrier to EHR programmes
  • The importance of funding as a barrier to EHR programmes
  • The importance of infrastructure as a barrier to EHR programmes
  • The importance of legal issues as a barrier to EHR programmes
  • The importance of other barriers to EHR programmes
  • The importance of policy as a barrier to EHR programmes
  • The importance of priorities as a barrier to EHR programmes
  • The importance of standards as a barrier to EHR programmes
  • Use of national EHR system by other care facilities, and proportion using it
  • Use of national EHR system by primary care facilities, and proportion using it
  • Use of national EHR system by secondary care facilities, and proportion using it
  • Use of national EHR system by tertiary care facilities, and proportion using it
  • Individuals have the legal right to specify which health-related data from their EHR can be shared with health professionals of their choice
  • Legislation exists that allows for the sharing of personal and health data between research entities
  • Legislation exists that allows individuals electronic access to their own health-related data when held in an EHR
  • Legislation exists that allows individuals to demand the deletion of health-related data from their EHR
  • Legislation exists that allows individuals to demand their own health-related data be corrected when held in an EHR if it is known to be inaccurate
  • Legislation exists that governs the international sharing of digital data between health professionals in health services through the use of an EHR
  • Legislation exists that governs the national sharing of digital data between health professionals in other health services through the use of an EHR
  • Legislation exists to protect the privacy of individuals' health-related data held in an EHR
  • Legislation exists to protect the privacy of personally identifiable data of individuals, irrespective of paper or digital formats
  • National policies or legislation to define medical jurisdiction, liability or reimbursement of eHealth services exist
  • Policies or legislation exist to address patient safety and quality of care based on data quality, data transmission standards or clinical competency criteria
  • Health care organizations use social media to help manage patient appointments
  • Health care organizations use social media to make emergency announcements
  • Health care organizations use social media to make general health announcements
  • Health care organizations use social media to promote health messages as a part of health promotion campaigns
  • Health care organizations use social media to seek feedback on services
  • Individuals and communities use social media to help decide on what health services to use
  • Individuals and communities use social media to learn about health issues
  • Individuals and communities use social media to participate in community-based health forums
  • Individuals and communities use social media to provide feedback to health facilities or health professionals
  • Individuals and communities use social media to run community-based health campaigns
  • National policy or strategy on the use of social media by government organizations exists
  • National policy or strategy on the use of social media by government organizations makes specific reference to its use in the health domain
  • National policy or strategy regulating the use of Big Data by private companies exists
  • National policy or strategy regulating the use of Big Data in the health sector exists
  • The importance of building capacity as a barrier to Big Data supporting universal health coverage
  • The importance of information sharing as a barrier to Big Data supporting universal health coverage
  • The importance of lack of integration as a barrier to Big Data supporting universal health coverage
  • The importance of new analytical methods as a barrier to Big Data supporting universal health coverage
  • The importance of privacy and security as a barrier to Big Data supporting universal health coverage
  • The importance of standards as a barrier to Big Data supporting universal health coverage
  • Healthy life years at age 65, Females
  • Healthy life years at age 65, Males
  • IHR - Chemical events
  • IHR - Coordination and National Focal Point communications
  • IHR - Food safety
  • IHR - Human resources
  • IHR - Laboratory
  • IHR - National legislation, policy and financing
  • IHR - Points of entry
  • IHR - Preparedness
  • IHR - Radionuclear emergencies
  • IHR - Response
  • IHR - Risk communication
  • IHR - Surveillance
  • IHR - Zoonotic events
  • AI strategy cross-sector
  • AI strategy for health
  • Oversight via advisory board
  • Oversight via existing agency
  • Oversight via independent body
  • Oversight via multiple agencies
  • Oversight via new agency
  • AI approval regulatory agency
  • AI auditing policies
  • AI certification policies
  • AI complaint/redress policies
  • AI procurement policies
  • Algorithmic impact guidance
  • Amend existing laws
  • Cross-sector guidance
  • Data accountability
  • Data protection impact guidance
  • Documentation and record-keeping
  • Environmental impact requirements
  • Ethical guidelines for AI
  • Ethics checklists/toolkits
  • Existing liability guidance for AI health
  • Fundamental rights impact guidance
  • Gap assessment in laws
  • General AI liability regime
  • Legislative measures for AI oversight
  • New AI health liability regime
  • New cross-sector AI laws
  • Post-market monitoring
  • Regulator knowledge-sharing
  • Risk management and cybersecurity
  • Risk-based approach adopted
  • Sector-specific AI laws
  • Sector-specific ethics guidance
  • Validation requirements
  • Voluntary industry codes
  • Data warehouse standards
  • EHR data extraction policies
  • Guidance on secondary data use
  • Health data authority
  • Health data governance framework
  • Health data hub
  • National health data strategy
  • Routine EHR data integration
  • Rules for cross-border data sharing
  • Rules for private data sharing
  • AI chatbots
  • AI diagnostics
  • AI for logistics/admin
  • AI prognosis prediction
  • AI remote monitoring
  • AI symptom checkers
  • AI-assisted surgery
  • Availability of public funding for assistive technology
  • Advance research and discovery
  • Improve care and outcomes
  • Increase efficiencies
  • Reduce inequalities
  • Reduce workforce pressure
  • Approval processes
  • Capacity barrier
  • Cultural barrier
  • Data quality/standards
  • Environmental impact
  • Evidence gap
  • Financial affordability
  • Infrastructure barrier
  • Job displacement
  • Legal uncertainty
  • Strategy barrier
  • Trust barrier
  • Cross-border partnerships
  • In-service AI training
  • New AI/data roles in health
  • Pre-service AI training
  • Private sector investment
  • Existence of financial mechanisms for assistive technology
  • Existence of regulations/standards/guidelines/protocols on assistive technology
  • Existence of initiatives/collaborations on assistive technology
  • Availability of government/registered services for assistive technology
  • Availability of education/training for assistive technology
  • Workforce availability for assistive technology
  • Barriers to accessing assistive products
  • Barriers to accessing assistive products, without spectacles
  • Funding sources for assistive products
  • Funding sources for assistive products, without spectacles
  • Sources of assistive products
  • Sources of assistive products, without spectacles
  • Satisfaction with assistive products and related services
  • Satisfaction with assistive products and related services, without spectacles
  • Satisfaction with assistive products for different environments and activities
  • Satisfaction with assistive products without spectacles for different environments and activities
  • Travel distance to obtain assistive products
  • Travel distance to obtain assistive products for rural residents
  • Travel distance to obtain assistive products for urban residents
  • Travel distance to obtain assistive products, without spectacles
  • Met need of assistive products as proportion of need by gender
  • Met need of assistive products as proportion of need by gender, no spectacles
  • Prevalence of need of assistive products by gender
  • Prevalence of need of assistive products by gender, no spectacles
  • Prevalence of use of assistive products by gender
  • Prevalence of use of assistive products by gender, no spectacles
  • Met need of assistive products as proportion of need, by age
  • Met need of assistive products as proportion of need, by age, no spectacles
  • Prevalence of need of assistive products by age group
  • Prevalence of need of assistive products by age group, no spectacles
  • Prevalence of use of assistive products by age group
  • Prevalence of use of assistive products by age group, no spectacles
  • Met need of assistive products as proportion of need by residence
  • Met need of assistive products as proportion of need by residence, no spectacles
  • Prevalence of need of assistive products by residence
  • Prevalence of need of assistive products by residence, no spectacles
  • Prevalence of use of assistive products other than spectacles, by residence
  • Prevalence of use of assistive products, by residence
  • Need and use of assistive product - Alarm signalers with light/sound/vibration
  • Need and use of assistive products - Audio-players with DAISY capability
  • Need and use of assistive products - Axillary/elbow crutches
  • Need and use of assistive products - Braille displays (note takers)
  • Need and use of assistive products - Braille writing equipment/braillers
  • Need and use of assistive products - Canes/sticks, tripod and quadripod
  • Need and use of assistive products - Chairs for shower/bath/toilet
  • Need and use of assistive products - Closed captioning displays
  • Need and use of assistive products - Club foot braces
  • Need and use of assistive products - Communication boards/books/cards
  • Need and use of assistive products - Communication software
  • Need and use of assistive products - Deafblind communicators for hearing
  • Need and use of assistive products - Deafblind communicators for vision
  • Need and use of assistive products - Fall detectors
  • Need and use of assistive products - Gesture to voice technology
  • Need and use of assistive products - GPS locators
  • Need and use of assistive products - Grab-bars / hand rails
  • Need and use of assistive products - Hearing aids
  • Need and use of assistive products - Hearing loops/FM systems
  • Need and use of assistive products - Incontinence products, absorbent
  • Need and use of assistive products - Keyboard and mouse emulation software
  • Need and use of assistive products - Magnifiers, digital handheld
  • Need and use of assistive products - Magnifiers, optical
  • Need and use of assistive products - Manual wheelchairs, basic type for active users
  • Need and use of assistive products - Manual wheelchairs, push type
  • Need and use of assistive products - Orthoses (lower limb)
  • Need and use of assistive products - Orthoses (spinal)
  • Need and use of assistive products - Orthoses (upper limb)
  • Need and use of assistive products - Personal emergency alarm systems
  • Need and use of assistive products - Pill organizers
  • Need and use of assistive products - Pressure relief cushions
  • Need and use of assistive products - Pressure relief mattresses
  • Need and use of assistive products - Prostheses (lower limb)
  • Need and use of assistive products - Prostheses (upper limb)
  • Need and use of assistive products - Ramps, portable
  • Need and use of assistive products - Recorders
  • Need and use of assistive products - Rollators
  • Need and use of assistive products - Screen readers
  • Need and use of assistive products - Simplified phones
  • Need and use of assistive products - Smartphones to support cognition
  • Need and use of assistive products - Smartphones to support commucation
  • Need and use of assistive products - Smartphones to support hearing
  • Need and use of assistive products - Smartphones to support vision
  • Need and use of assistive products - Spectacles
  • Need and use of assistive products - Standing frames, adjustable
  • Need and use of assistive products - Therapeutic footwear
  • Need and use of assistive products - Time management products
  • Need and use of assistive products - Travel aids
  • Need and use of assistive products - Tricycles
  • Need and use of assistive products - Video communication devices
  • Need and use of assistive products - Walking frames/walkers
  • Need and use of assistive products - Watches, talking/touching
  • Need and use of assistive products - Wheelchairs, electrically powered
  • Need and use of assistive products - Wheelchairs, manual with postural support
  • Need and use of assistive products - White canes
  • Antibiotic consumption (%)
  • Air pollution mortality rate per 100 000 population
  • Air pollution mortality rate, females
  • Air pollution mortality rate, males
  • Urban air pollution
  • Road traffic death rate per 100 000 population
  • Road traffic death rate, females
  • Road traffic death rate, males
  • Population using safe drinking water (%)
  • Population using safe sanitation (%)
  • Antiretroviral therapy coverage (%)
  • MDRTB treatment success rate (%)
  • Hepatitis C treatment coverage (%)
  • Suicide mortality rate per 100 000 population
  • Suicide mortality rate, females
  • Suicide mortality rate, males
  • Premature NCD mortality (%)
  • Premature NCD mortality (%), females
  • Premature NCD mortality (%), males
  • Raised blood pressure prevalence (%)
  • Tobacco use prevalence (%)
  • Tobacco use prevalence (%), females
  • Tobacco use prevalence (%), males
  • Obesity prevalence (%)
  • Overweight prevalence (%)
  • Pneumococcal vaccination coverage (%)
  • Child obesity prevalence (%)
  • Child obesity prevalence (%), females
  • Child obesity prevalence (%), males
  • Child overweight prevalence (%)
  • Child overweight prevalence (%), females
  • Child overweight prevalence (%), males
  • Trans-fatty acids policy implementation
  • Pure alcohol consumption, litres per capita, age 15+
  • Children vaccinated against measles (%)
  • Member States that have HPV vaccination (%)
  • Estimated maternal mortality per 100 000 live births (WHO/UNICEFF/UNFPA estimates)
  • Dentists per 10 000 population
  • Health workforce per 10 000 population
  • Medical doctors per 10 000 population
  • Midwives per 10 000 population
  • Nurses per 10 000 population
  • Pharmacists per 10 000 population
  • Violence against women (%)
  • Hospital access per 100 000 population
  • IHR average of capacities
  • National digital health policy or strategy
  • National health information system (HIS) policy or strategy
  • National telehealth policy or strategy
  • Donor/non-public funding
  • Private or commercial funding
  • Public funding
  • Public-private partnerships
  • Digital health education action plan, policy or strategy
  • Health professionals: in-service training in digital health
  • Health science students: certified training in digital health
  • Allows individuals electronic access to their own health-related data when held in an EHR
  • Allows individuals to demand the deletion of health-related data from their EHR
  • Allows individuals to demand their own health-related data be corrected when held in an EHR if it is known to be inaccurate
  • Allows individuals to specify which health-related data from their EHR can be shared with health professionals of their choice
  • Governs the secure identification of patients and health care providers
  • Governs the sharing of digital data between health professionals and across care settings through the use of an EHR
  • Protects the privacy of individuals' health-related data held in electronic format in an EHR
  • Protects the privacy of personally identifiable data
  • Developed guidance for evaluating digital health interventions
  • Evaluation of mHealth service or programmes
  • Evaluation of telehealth programmes
  • Government agency or organisation responsible for national monitoring
  • Government agency or organisation responsible for regional monitoring
  • National EHR system
  • Regional EHR system
  • Regional EHR systems connected or federated at national level
  • Primary care facilities (e.g. clinics and health care centres)
  • Secondary care facilities (e.g. hospitals, emergency care)
  • Tertiary care facilities (e.g. specialized care, referral from primary/secondary care)
  • Electronic prescription of medications
  • Receive clinical/patient medical information securely from other professionals
  • Receive lab test results
  • Receive patient summaries
  • Receive summary of the care received during a hospitalization upon discharge (such as discharge summary)
  • Send order/request for lab test
  • Sharing of clinical/patient medical information with other health professionals
  • National digital health patient portal
  • Booking of medical appointments
  • Bring together relevant health-related information
  • Patient access to their medical history and data
  • Provider access to patient's clinical information
  • Shared platform for communication
  • Teledermatology
  • Telemedicine
  • Telepathology
  • Telepsychiatry
  • Teleradiology
  • Access to electronic patient information
  • Appointment reminders
  • Health promotion
  • Mobile teleconsultation
  • Patient monitoring
  • Surveillance
  • Treatment adherence
  • Feedback on health care services
  • General public health announcements
  • Health promotion
  • Management of disasters and emergencies
  • Mindfulness and mental health
  • COVID-19 symptom checking
  • Diet and nutrition
  • Exercise and fitness
  • Women's health
  • Booking care provider consultation
  • Booking COVID-19 testing
  • Booking COVID-19 vaccination
  • COVID-19 contact-tracing or proximity-tracing
  • Governs data extraction from EHR systems for regional/local or national registries and databases
  • Governs the use of big data in the health sector
  • Governs the use of big data in the private sector
  • Overarching national data strategy
  • Adoption of international terminology standards
  • Interoperability strategy or policy
  • Responsible national organization or agency
  • CDR(0 year), All causes, per 100 000
  • CDR(0 year), Infectious and parasitic diseases, per 100 000
  • CDR(1-4), All causes, per 100 000
  • CDR(1-4), Infectious and parasitic diseases, per 100 000
  • Deaths(#), AIDS/HIV (as recorded by routine mortality statistics system)
  • Deaths(#), All causes
  • Deaths(#), Infectious and parasitic diseases
  • Deaths(#), Intestinal infectious diseases
  • Deaths(#), Meningococcal infection
  • Deaths(#), Tuberculosis
  • Deaths(#), Viral hepatitis
  • SDR, AIDS/HIV (as recorded by routine mortality statistics system), per 100 000
  • SDR, All causes, per 100 000
  • SDR, Infectious and parasitic diseases, per 100 000
  • SDR, Intestinal infectious diseases, per 100 000
  • SDR, Meningococcal infection, per 100 000
  • SDR, Tuberculosis, per 100 000
  • SDR, Viral hepatitis, per 100 000
  • SDR(0-14), AIDS/HIV (as recorded by routine mortality statistics system), per 100 000
  • SDR(0-14), All causes, per 100 000
  • SDR(0-14), Infectious and parasitic diseases, per 100 000
  • SDR(0-14), Intestinal infectious diseases, per 100 000
  • SDR(0-14), Meningococcal infection, per 100 000
  • SDR(0-14), Tuberculosis, per 100 000
  • SDR(0-14), Viral hepatitis, per 100 000
  • SDR(0-64), AIDS/HIV (as recorded by routine mortality statistics system), per 100 000
  • SDR(0-64), All causes, per 100 000
  • SDR(0-64), Infectious and parasitic diseases, per 100 000
  • SDR(0-64), Intestinal infectious diseases, per 100 000
  • SDR(0-64), Meningococcal infection, per 100 000
  • SDR(0-64), Tuberculosis, per 100 000
  • SDR(0-64), Viral hepatitis, per 100 000
  • SDR(1-19), All causes, per 100 000
  • SDR(1-19), Infectious and parasitic diseases, per 100 000
  • SDR(15-24), All causes, per 100 000
  • SDR(15-24), Infectious and parasitic diseases, per 100 000
  • SDR(15-29), AIDS/HIV (as recorded by routine mortality statistics system), per 100 000
  • SDR(15-29), All causes, per 100 000
  • SDR(15-29), Infectious and parasitic diseases, per 100 000
  • SDR(15-29), Intestinal infectious diseases, per 100 000
  • SDR(15-29), Meningococcal infection, per 100 000
  • SDR(15-29), Tuberculosis, per 100 000
  • SDR(15-29), Viral hepatitis, per 100 000
  • SDR(25-64), AIDS/HIV (as recorded by routine mortality statistics system), per 100 000
  • SDR(25-64), All causes, per 100 000
  • SDR(25-64), Infectious and parasitic diseases, per 100 000
  • SDR(25-64), Intestinal infectious diseases, per 100 000
  • SDR(25-64), Meningococcal infection, per 100 000
  • SDR(25-64), Tuberculosis, per 100 000
  • SDR(25-64), Viral hepatitis, per 100 000
  • SDR(30-44), AIDS/HIV (as recorded by routine mortality statistics system), per 100 000
  • SDR(30-44), All causes, per 100 000
  • SDR(30-44), Infectious and parasitic diseases, per 100 000
  • SDR(30-44), Intestinal infectious diseases, per 100 000
  • SDR(30-44), Meningococcal infection, per 100 000
  • SDR(30-44), Tuberculosis, per 100 000
  • SDR(30-44), Viral hepatitis, per 100 000
  • SDR(45-59), AIDS/HIV (as recorded by routine mortality statistics system), per 100 000
  • SDR(45-59), All causes, per 100 000
  • SDR(45-59), Infectious and parasitic diseases, per 100 000
  • SDR(45-59), Intestinal infectious diseases, per 100 000
  • SDR(45-59), Meningococcal infection, per 100 000
  • SDR(45-59), Tuberculosis, per 100 000
  • SDR(45-59), Viral hepatitis, per 100 000
  • SDR(5-14), All causes, per 100 000
  • SDR(5-14), Infectious and parasitic diseases, per 100 000
  • SDR(60-74), AIDS/HIV (as recorded by routine mortality statistics system), per 100 000
  • SDR(60-74), All causes, per 100 000
  • SDR(60-74), Infectious and parasitic diseases, per 100 000
  • SDR(60-74), Intestinal infectious diseases, per 100 000
  • SDR(60-74), Meningococcal infection, per 100 000
  • SDR(60-74), Tuberculosis, per 100 000
  • SDR(60-74), Viral hepatitis, per 100 000
  • SDR(65+), AIDS/HIV (as recorded by routine mortality statistics system), per 100 000
  • SDR(65+), All causes, per 100 000
  • SDR(65+), Infectious and parasitic diseases, per 100 000
  • SDR(65+), Intestinal infectious diseases, per 100 000
  • SDR(65+), Meningococcal infection, per 100 000
  • SDR(65+), Tuberculosis, per 100 000
  • SDR(65+), Viral hepatitis, per 100 000
  • SDR(75+), AIDS/HIV (as recorded by routine mortality statistics system), per 100 000
  • SDR(75+), All causes, per 100 000
  • SDR(75+), Infectious and parasitic diseases, per 100 000
  • SDR(75+), Intestinal infectious diseases, per 100 000
  • SDR(75+), Meningococcal infection, per 100 000
  • SDR(75+), Tuberculosis, per 100 000
  • SDR(75+), Viral hepatitis, per 100 000
  • CDR(0 year), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
  • CDR(0 year), Malignant neoplasms, per 100 000
  • CDR(0 year), Neoplasms, per 100 000
  • CDR(1-4), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
  • CDR(1-4), Malignant neoplasms, per 100 000
  • CDR(1-4), Neoplasms, per 100 000
  • Deaths(#), females, Malignant neoplasm of cervix uteri
  • Deaths(#), females, Malignant neoplasm of other parts of uterus
  • Deaths(#), females, Malignant neoplasm of ovary
  • Deaths(#), males, Malignant neoplasm of prostate
  • Deaths(#), Malignant melanoma of skin
  • Deaths(#), Malignant neoplasm of bladder
  • Deaths(#), Malignant neoplasm of breast
  • Deaths(#), Malignant neoplasm of colon, rectum and anus
  • Deaths(#), Malignant neoplasm of esophagus
  • Deaths(#), Malignant neoplasm of larynx, trachea, bronchus and lung
  • Deaths(#), Malignant neoplasm of lip/oral cavity/pharynx
  • Deaths(#), Malignant neoplasm of liver and intrahepatic bile ducts
  • Deaths(#), Malignant neoplasm of lymphoid and haematopoietic tissue
  • Deaths(#), Malignant neoplasm of pancreas
  • Deaths(#), Malignant neoplasm of stomach
  • Deaths(#), Malignant neoplasm of trachea, bronchus and lung
  • Deaths(#), Malignant neoplasms
  • Deaths(#), Neoplasms
  • SDR, females, Malignant neoplasm of cervix uteri, per 100 000
  • SDR, females, Malignant neoplasm of other parts of uterus, per 100 000
  • SDR, females, Malignant neoplasm of ovary, per 100 000
  • SDR, males, Malignant neoplasm of prostate, per 100 000
  • SDR, Malignant melanoma of skin, per 100 000
  • SDR, Malignant neoplasm of bladder, per 100 000
  • SDR, Malignant neoplasm of breast, per 100 000
  • SDR, Malignant neoplasm of colon, rectum and anus, per 100 000
  • SDR, Malignant neoplasm of esophagus, per 100 000
  • SDR, Malignant neoplasm of larynx, trachea, bronchus and lung, per 100 000
  • SDR, Malignant neoplasm of lip/oral cavity/pharynx, per 100 000
  • SDR, Malignant neoplasm of liver and intrahepatic bile ducts, per 100 000
  • SDR, Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
  • SDR, Malignant neoplasm of pancreas, per 100 000
  • SDR, Malignant neoplasm of stomach, per 100 000
  • SDR, Malignant neoplasm of trachea, bronchus and lung, per 100 000
  • SDR, Malignant neoplasms, per 100 000
  • SDR, Neoplasms, per 100 000
  • SDR(0-14), females, Malignant neoplasm of cervix uteri, per 100 000
  • SDR(0-14), females, Malignant neoplasm of other parts of uterus, per 100 000
  • SDR(0-14), females, Malignant neoplasm of ovary, per 100 000
  • SDR(0-14), males, Malignant neoplasm of prostate, per 100 000
  • SDR(0-14), Malignant melanoma of skin, per 100 000
  • SDR(0-14), Malignant neoplasm of bladder, per 100 000
  • SDR(0-14), Malignant neoplasm of breast, per 100 000
  • SDR(0-14), Malignant neoplasm of colon, rectum and anus, per 100 000
  • SDR(0-14), Malignant neoplasm of esophagus, per 100 000
  • SDR(0-14), Malignant neoplasm of larynx, trachea, bronchus and lung, per 100 000
  • SDR(0-14), Malignant neoplasm of lip/oral cavity/pharynx, per 100 000
  • SDR(0-14), Malignant neoplasm of liver and intrahepatic bile ducts, per 100 000
  • SDR(0-14), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
  • SDR(0-14), Malignant neoplasm of pancreas, per 100 000
  • SDR(0-14), Malignant neoplasm of stomach, per 100 000
  • SDR(0-14), Malignant neoplasm of trachea, bronchus and lung, per 100 000
  • SDR(0-14), Malignant neoplasms, per 100 000
  • SDR(0-14), Neoplasms, per 100 000
  • SDR(0-64), females, Malignant neoplasm of cervix uteri, per 100 000
  • SDR(0-64), females, Malignant neoplasm of other parts of uterus, per 100 000
  • SDR(0-64), females, Malignant neoplasm of ovary, per 100 000
  • SDR(0-64), males, Malignant neoplasm of prostate, per 100 000
  • SDR(0-64), Malignant melanoma of skin, per 100 000
  • SDR(0-64), Malignant neoplasm of bladder, per 100 000
  • SDR(0-64), Malignant neoplasm of breast, per 100 000
  • SDR(0-64), Malignant neoplasm of colon, rectum and anus, per 100 000
  • SDR(0-64), Malignant neoplasm of esophagus, per 100 000
  • SDR(0-64), Malignant neoplasm of larynx, trachea, bronchus and lung, per 100 000
  • SDR(0-64), Malignant neoplasm of lip/oral cavity/pharynx, per 100 000
  • SDR(0-64), Malignant neoplasm of liver and intrahepatic bile ducts, per 100 000
  • SDR(0-64), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
  • SDR(0-64), Malignant neoplasm of pancreas, per 100 000
  • SDR(0-64), Malignant neoplasm of stomach, per 100 000
  • SDR(0-64), Malignant neoplasm of trachea, bronchus and lung, per 100 000
  • SDR(0-64), Malignant neoplasms, per 100 000
  • SDR(0-64), Neoplasms, per 100 000
  • SDR(1-19), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
  • SDR(1-19), Malignant neoplasms, per 100 000
  • SDR(1-19), Neoplasms, per 100 000
  • SDR(15-24), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
  • SDR(15-24), Malignant neoplasms, per 100 000
  • SDR(15-24), Neoplasms, per 100 000
  • SDR(15-29), females, Malignant neoplasm of cervix uteri, per 100 000
  • SDR(15-29), females, Malignant neoplasm of other parts of uterus, per 100 000
  • SDR(15-29), females, Malignant neoplasm of ovary, per 100 000
  • SDR(15-29), males, Malignant neoplasm of prostate, per 100 000
  • SDR(15-29), Malignant melanoma of skin, per 100 000
  • SDR(15-29), Malignant neoplasm of bladder, per 100 000
  • SDR(15-29), Malignant neoplasm of breast, per 100 000
  • SDR(15-29), Malignant neoplasm of colon, rectum and anus, per 100 000
  • SDR(15-29), Malignant neoplasm of esophagus, per 100 000
  • SDR(15-29), Malignant neoplasm of larynx, trachea, bronchus and lung, per 100 000
  • SDR(15-29), Malignant neoplasm of lip/oral cavity/pharynx, per 100 000
  • SDR(15-29), Malignant neoplasm of liver and intrahepatic bile ducts, per 100 000
  • SDR(15-29), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
  • SDR(15-29), Malignant neoplasm of pancreas, per 100 000
  • SDR(15-29), Malignant neoplasm of stomach, per 100 000
  • SDR(15-29), Malignant neoplasm of trachea, bronchus and lung, per 100 000
  • SDR(15-29), Malignant neoplasms, per 100 000
  • SDR(15-29), Neoplasms, per 100 000
  • SDR(25-64), females, Malignant neoplasm of cervix uteri, per 100 000
  • SDR(25-64), females, Malignant neoplasm of other parts of uterus, per 100 000
  • SDR(25-64), females, Malignant neoplasm of ovary, per 100 000
  • SDR(25-64), males, Malignant neoplasm of prostate, per 100 000
  • SDR(25-64), Malignant melanoma of skin, per 100 000
  • SDR(25-64), Malignant neoplasm of bladder, per 100 000
  • SDR(25-64), Malignant neoplasm of breast, per 100 000
  • SDR(25-64), Malignant neoplasm of colon, rectum and anus, per 100 000
  • SDR(25-64), Malignant neoplasm of esophagus, per 100 000
  • SDR(25-64), Malignant neoplasm of larynx, trachea, bronchus and lung, per 100 000
  • SDR(25-64), Malignant neoplasm of lip/oral cavity/pharynx, per 100 000
  • SDR(25-64), Malignant neoplasm of liver and intrahepatic bile ducts, per 100 000
  • SDR(25-64), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
  • SDR(25-64), Malignant neoplasm of pancreas, per 100 000
  • SDR(25-64), Malignant neoplasm of stomach, per 100 000
  • SDR(25-64), Malignant neoplasm of trachea, bronchus and lung, per 100 000
  • SDR(25-64), Malignant neoplasms, per 100 000
  • SDR(25-64), Neoplasms, per 100 000
  • SDR(30-44), females, Malignant neoplasm of cervix uteri, per 100 000
  • SDR(30-44), females, Malignant neoplasm of other parts of uterus, per 100 000
  • SDR(30-44), females, Malignant neoplasm of ovary, per 100 000
  • SDR(30-44), males, Malignant neoplasm of prostate, per 100 000
  • SDR(30-44), Malignant melanoma of skin, per 100 000
  • SDR(30-44), Malignant neoplasm of bladder, per 100 000
  • SDR(30-44), Malignant neoplasm of breast, per 100 000
  • SDR(30-44), Malignant neoplasm of colon, rectum and anus, per 100 000
  • SDR(30-44), Malignant neoplasm of esophagus, per 100 000
  • SDR(30-44), Malignant neoplasm of larynx, trachea, bronchus and lung, per 100 000
  • SDR(30-44), Malignant neoplasm of lip/oral cavity/pharynx, per 100 000
  • SDR(30-44), Malignant neoplasm of liver and intrahepatic bile ducts, per 100 000
  • SDR(30-44), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
  • SDR(30-44), Malignant neoplasm of pancreas, per 100 000
  • SDR(30-44), Malignant neoplasm of stomach, per 100 000
  • SDR(30-44), Malignant neoplasm of trachea, bronchus and lung, per 100 000
  • SDR(30-44), Malignant neoplasms, per 100 000
  • SDR(30-44), Neoplasms, per 100 000
  • SDR(45-59), females, Malignant neoplasm of cervix uteri, per 100 000
  • SDR(45-59), females, Malignant neoplasm of other parts of uterus, per 100 000
  • SDR(45-59), females, Malignant neoplasm of ovary, per 100 000
  • SDR(45-59), males, Malignant neoplasm of prostate, per 100 000
  • SDR(45-59), Malignant melanoma of skin, per 100 000
  • SDR(45-59), Malignant neoplasm of bladder, per 100 000
  • SDR(45-59), Malignant neoplasm of breast, per 100 000
  • SDR(45-59), Malignant neoplasm of colon, rectum and anus, per 100 000
  • SDR(45-59), Malignant neoplasm of esophagus, per 100 000
  • SDR(45-59), Malignant neoplasm of larynx, trachea, bronchus and lung, per 100 000
  • SDR(45-59), Malignant neoplasm of lip/oral cavity/pharynx, per 100 000
  • SDR(45-59), Malignant neoplasm of liver and intrahepatic bile ducts, per 100 000
  • SDR(45-59), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
  • SDR(45-59), Malignant neoplasm of pancreas, per 100 000
  • SDR(45-59), Malignant neoplasm of stomach, per 100 000
  • SDR(45-59), Malignant neoplasm of trachea, bronchus and lung, per 100 000
  • SDR(45-59), Malignant neoplasms, per 100 000
  • SDR(45-59), Neoplasms, per 100 000
  • SDR(5-14), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
  • SDR(5-14), Malignant neoplasms, per 100 000
  • SDR(5-14), Neoplasms, per 100 000
  • SDR(60-74), females, Malignant neoplasm of cervix uteri, per 100 000
  • SDR(60-74), females, Malignant neoplasm of other parts of uterus, per 100 000
  • SDR(60-74), females, Malignant neoplasm of ovary, per 100 000
  • SDR(60-74), males, Malignant neoplasm of prostate, per 100 000
  • SDR(60-74), Malignant melanoma of skin, per 100 000
  • SDR(60-74), Malignant neoplasm of bladder, per 100 000
  • SDR(60-74), Malignant neoplasm of breast, per 100 000
  • SDR(60-74), Malignant neoplasm of colon, rectum and anus, per 100 000
  • SDR(60-74), Malignant neoplasm of esophagus, per 100 000
  • SDR(60-74), Malignant neoplasm of larynx, trachea, bronchus and lung, per 100 000
  • SDR(60-74), Malignant neoplasm of lip/oral cavity/pharynx, per 100 000
  • SDR(60-74), Malignant neoplasm of liver and intrahepatic bile ducts, per 100 000
  • SDR(60-74), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
  • SDR(60-74), Malignant neoplasm of pancreas, per 100 000
  • SDR(60-74), Malignant neoplasm of stomach, per 100 000
  • SDR(60-74), Malignant neoplasm of trachea, bronchus and lung, per 100 000
  • SDR(60-74), Malignant neoplasms, per 100 000
  • SDR(60-74), Neoplasms, per 100 000
  • SDR(65+), females, Malignant neoplasm of cervix uteri, per 100 000
  • SDR(65+), females, Malignant neoplasm of other parts of uterus, per 100 000
  • SDR(65+), females, Malignant neoplasm of ovary, per 100 000
  • SDR(65+), males, Malignant neoplasm of prostate, per 100 000
  • SDR(65+), Malignant melanoma of skin, per 100 000
  • SDR(65+), Malignant neoplasm of bladder, per 100 000
  • SDR(65+), Malignant neoplasm of breast, per 100 000
  • SDR(65+), Malignant neoplasm of colon, rectum and anus, per 100 000
  • SDR(65+), Malignant neoplasm of esophagus, per 100 000
  • SDR(65+), Malignant neoplasm of larynx, trachea, bronchus and lung, per 100 000
  • SDR(65+), Malignant neoplasm of lip/oral cavity/pharynx, per 100 000
  • SDR(65+), Malignant neoplasm of liver and intrahepatic bile ducts, per 100 000
  • SDR(65+), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
  • SDR(65+), Malignant neoplasm of pancreas, per 100 000
  • SDR(65+), Malignant neoplasm of stomach, per 100 000
  • SDR(65+), Malignant neoplasm of trachea, bronchus and lung, per 100 000
  • SDR(65+), Malignant neoplasms, per 100 000
  • SDR(65+), Neoplasms, per 100 000
  • SDR(75+), females, Malignant neoplasm of cervix uteri, per 100 000
  • SDR(75+), females, Malignant neoplasm of other parts of uterus, per 100 000
  • SDR(75+), females, Malignant neoplasm of ovary, per 100 000
  • SDR(75+), males, Malignant neoplasm of prostate, per 100 000
  • SDR(75+), Malignant melanoma of skin, per 100 000
  • SDR(75+), Malignant neoplasm of bladder, per 100 000
  • SDR(75+), Malignant neoplasm of breast, per 100 000
  • SDR(75+), Malignant neoplasm of colon, rectum and anus, per 100 000
  • SDR(75+), Malignant neoplasm of esophagus, per 100 000
  • SDR(75+), Malignant neoplasm of larynx, trachea, bronchus and lung, per 100 000
  • SDR(75+), Malignant neoplasm of lip/oral cavity/pharynx, per 100 000
  • SDR(75+), Malignant neoplasm of liver and intrahepatic bile ducts, per 100 000
  • SDR(75+), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
  • SDR(75+), Malignant neoplasm of pancreas, per 100 000
  • SDR(75+), Malignant neoplasm of stomach, per 100 000
  • SDR(75+), Malignant neoplasm of trachea, bronchus and lung, per 100 000
  • SDR(75+), Malignant neoplasms, per 100 000
  • SDR(75+), Neoplasms, per 100 000
  • CDR(0 year), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
  • CDR(0 year), Endocrine, nutritional and metabolic diseases, per 100 000
  • CDR(1-4), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
  • CDR(1-4), Endocrine, nutritional and metabolic diseases, per 100 000
  • Deaths(#), Alcohol abuse (including alcoholic psychosis)
  • Deaths(#), Alzheimer's disease and other degenerative diseases of nervous system
  • Deaths(#), Diabetes mellitus
  • Deaths(#), Diseases of nervous system and sense organs
  • Deaths(#), Diseases of the blood, blood forming organs and certain immunity disorders
  • Deaths(#), Drug dependence and toxicomania
  • Deaths(#), Endocrine, nutritional and metabolic diseases
  • Deaths(#), Meningitis
  • Deaths(#), Mental and behavioural disorders
  • Deaths(#), Psychoactive substance use
  • SDR, Alcohol abuse (including alcoholic psychosis), per 100 000
  • SDR, Alzheimer's disease and other degenerative diseases of nervous system, per 100 000
  • SDR, Diabetes mellitus, per 100 000
  • SDR, Diseases of nervous system and sense organs, per 100 000
  • SDR, Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
  • SDR, Drug dependence and toxicomania, per 100 000
  • SDR, Endocrine, nutritional and metabolic diseases, per 100 000
  • SDR, Meningitis, per 100 000
  • SDR, Mental and behavioural disorders, per 100 000
  • SDR, Psychoactive substance use, per 100 000
  • SDR(0-14), Alcohol abuse (including alcoholic psychosis), per 100 000
  • SDR(0-14), Alzheimer's disease and other degenerative diseases of nervous system, per 100 000
  • SDR(0-14), Diabetes mellitus, per 100 000
  • SDR(0-14), Diseases of nervous system and sense organs, per 100 000
  • SDR(0-14), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
  • SDR(0-14), Drug dependence and toxicomania, per 100 000
  • SDR(0-14), Endocrine, nutritional and metabolic diseases, per 100 000
  • SDR(0-14), Meningitis, per 100 000
  • SDR(0-14), Mental and behavioural disorders, per 100 000
  • SDR(0-14), Psychoactive substance use, per 100 000
  • SDR(0-64), Alcohol abuse (including alcoholic psychosis), per 100 000
  • SDR(0-64), Alzheimer's disease and other degenerative diseases of nervous system, per 100 000
  • SDR(0-64), Diabetes mellitus, per 100 000
  • SDR(0-64), Diseases of nervous system and sense organs, per 100 000
  • SDR(0-64), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
  • SDR(0-64), Drug dependence and toxicomania, per 100 000
  • SDR(0-64), Endocrine, nutritional and metabolic diseases, per 100 000
  • SDR(0-64), Meningitis, per 100 000
  • SDR(0-64), Mental and behavioural disorders, per 100 000
  • SDR(0-64), Psychoactive substance use, per 100 000
  • SDR(1-19), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
  • SDR(1-19), Endocrine, nutritional and metabolic diseases, per 100 000
  • SDR(15-24), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
  • SDR(15-24), Endocrine, nutritional and metabolic diseases, per 100 000
  • SDR(15-29), Alcohol abuse (including alcoholic psychosis), per 100 000
  • SDR(15-29), Alzheimer's disease and other degenerative diseases of nervous system, per 100 000
  • SDR(15-29), Diabetes mellitus, per 100 000
  • SDR(15-29), Diseases of nervous system and sense organs, per 100 000
  • SDR(15-29), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
  • SDR(15-29), Drug dependence and toxicomania, per 100 000
  • SDR(15-29), Endocrine, nutritional and metabolic diseases, per 100 000
  • SDR(15-29), Meningitis, per 100 000
  • SDR(15-29), Mental and behavioural disorders, per 100 000
  • SDR(15-29), Psychoactive substance use, per 100 000
  • SDR(25-64), Alcohol abuse (including alcoholic psychosis), per 100 000
  • SDR(25-64), Alzheimer's disease and other degenerative diseases of nervous system, per 100 000
  • SDR(25-64), Diabetes mellitus, per 100 000
  • SDR(25-64), Diseases of nervous system and sense organs, per 100 000
  • SDR(25-64), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
  • SDR(25-64), Drug dependence and toxicomania, per 100 000
  • SDR(25-64), Endocrine, nutritional and metabolic diseases, per 100 000
  • SDR(25-64), Meningitis, per 100 000
  • SDR(25-64), Mental and behavioural disorders, per 100 000
  • SDR(25-64), Psychoactive substance use, per 100 000
  • SDR(30-44), Alcohol abuse (including alcoholic psychosis), per 100 000
  • SDR(30-44), Alzheimer's disease and other degenerative diseases of nervous system, per 100 000
  • SDR(30-44), Diabetes mellitus, per 100 000
  • SDR(30-44), Diseases of nervous system and sense organs, per 100 000
  • SDR(30-44), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
  • SDR(30-44), Drug dependence and toxicomania, per 100 000
  • SDR(30-44), Endocrine, nutritional and metabolic diseases, per 100 000
  • SDR(30-44), Meningitis, per 100 000
  • SDR(30-44), Mental and behavioural disorders, per 100 000
  • SDR(30-44), Psychoactive substance use, per 100 000
  • SDR(45-59), Alcohol abuse (including alcoholic psychosis), per 100 000
  • SDR(45-59), Alzheimer's disease and other degenerative diseases of nervous system, per 100 000
  • SDR(45-59), Diabetes mellitus, per 100 000
  • SDR(45-59), Diseases of nervous system and sense organs, per 100 000
  • SDR(45-59), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
  • SDR(45-59), Drug dependence and toxicomania, per 100 000
  • SDR(45-59), Endocrine, nutritional and metabolic diseases, per 100 000
  • SDR(45-59), Meningitis, per 100 000
  • SDR(45-59), Mental and behavioural disorders, per 100 000
  • SDR(45-59), Psychoactive substance use, per 100 000
  • SDR(5-14), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
  • SDR(5-14), Endocrine, nutritional and metabolic diseases, per 100 000
  • SDR(60-74), Alcohol abuse (including alcoholic psychosis), per 100 000
  • SDR(60-74), Alzheimer's disease and other degenerative diseases of nervous system, per 100 000
  • SDR(60-74), Diabetes mellitus, per 100 000
  • SDR(60-74), Diseases of nervous system and sense organs, per 100 000
  • SDR(60-74), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
  • SDR(60-74), Drug dependence and toxicomania, per 100 000
  • SDR(60-74), Endocrine, nutritional and metabolic diseases, per 100 000
  • SDR(60-74), Meningitis, per 100 000
  • SDR(60-74), Mental and behavioural disorders, per 100 000
  • SDR(60-74), Psychoactive substance use, per 100 000
  • SDR(65+), Alcohol abuse (including alcoholic psychosis), per 100 000
  • SDR(65+), Alzheimer's disease and other degenerative diseases of nervous system, per 100 000
  • SDR(65+), Diabetes mellitus, per 100 000
  • SDR(65+), Diseases of nervous system and sense organs, per 100 000
  • SDR(65+), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
  • SDR(65+), Drug dependence and toxicomania, per 100 000
  • SDR(65+), Endocrine, nutritional and metabolic diseases, per 100 000
  • SDR(65+), Meningitis, per 100 000
  • SDR(65+), Mental and behavioural disorders, per 100 000
  • SDR(65+), Psychoactive substance use, per 100 000
  • SDR(75+), Alcohol abuse (including alcoholic psychosis), per 100 000
  • SDR(75+), Alzheimer's disease and other degenerative diseases of nervous system, per 100 000
  • SDR(75+), Diabetes mellitus, per 100 000
  • SDR(75+), Diseases of nervous system and sense organs, per 100 000
  • SDR(75+), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
  • SDR(75+), Drug dependence and toxicomania, per 100 000
  • SDR(75+), Endocrine, nutritional and metabolic diseases, per 100 000
  • SDR(75+), Meningitis, per 100 000
  • SDR(75+), Mental and behavioural disorders, per 100 000
  • SDR(75+), Psychoactive substance use, per 100 000
  • CDR(0 year), Diseases of the circulatory system, per 100 000
  • CDR(0 year), Diseases of the respiratory system, per 100 000
  • CDR(0 year), Pneumonia, per 100 000
  • CDR(1-4), Diseases of the circulatory system, per 100 000
  • CDR(1-4), Diseases of the respiratory system, per 100 000
  • CDR(1-4), Pneumonia, per 100 000
  • Deaths(#), Asthma
  • Deaths(#), Cerebrovascular diseases
  • Deaths(#), Chronic lower respiratory diseases
  • Deaths(#), Diseases of the circulatory system
  • Deaths(#), Diseases of the respiratory system
  • Deaths(#), Influenza
  • Deaths(#), Ischaemic heart disease
  • Deaths(#), Other acute respiratory infections
  • Deaths(#), Pneumonia
  • Deaths(#), Pulmonary heart disease and other heart diseases
  • SDR, Asthma, per 100 000
  • SDR, Cerebrovascular diseases, per 100 000
  • SDR, Chronic lower respiratory diseases, per 100 000
  • SDR, Diseases of the circulatory system, per 100 000
  • SDR, Diseases of the respiratory system, per 100 000
  • SDR, Influenza, per 100 000
  • SDR, Ischaemic heart disease, per 100 000
  • SDR, Other acute respiratory infections, per 100 000
  • SDR, Pneumonia, per 100 000
  • SDR, Pulmonary heart disease and other heart diseases, per 100 000
  • SDR(0-14), Asthma, per 100 000
  • SDR(0-14), Cerebrovascular diseases, per 100 000
  • SDR(0-14), Chronic lower respiratory diseases, per 100 000
  • SDR(0-14), Diseases of the circulatory system, per 100 000
  • SDR(0-14), Diseases of the respiratory system, per 100 000
  • SDR(0-14), Influenza, per 100 000
  • SDR(0-14), Ischaemic heart disease, per 100 000
  • SDR(0-14), Other acute respiratory infections, per 100 000
  • SDR(0-14), Pneumonia, per 100 000
  • SDR(0-14), Pulmonary heart disease and other heart diseases, per 100 000
  • SDR(0-64), Asthma, per 100 000
  • SDR(0-64), Cerebrovascular diseases, per 100 000
  • SDR(0-64), Chronic lower respiratory diseases, per 100 000
  • SDR(0-64), Diseases of the circulatory system, per 100 000
  • SDR(0-64), Diseases of the respiratory system, per 100 000
  • SDR(0-64), Influenza, per 100 000
  • SDR(0-64), Ischaemic heart disease, per 100 000
  • SDR(0-64), Other acute respiratory infections, per 100 000
  • SDR(0-64), Pneumonia, per 100 000
  • SDR(0-64), Pulmonary heart disease and other heart diseases, per 100 000
  • SDR(1-19), Diseases of the circulatory system, per 100 000
  • SDR(1-19), Diseases of the respiratory system, per 100 000
  • SDR(1-19), Pneumonia, per 100 000
  • SDR(15-24), Diseases of the circulatory system, per 100 000
  • SDR(15-24), Diseases of the respiratory system, per 100 000
  • SDR(15-24), Pneumonia, per 100 000
  • SDR(15-29), Asthma, per 100 000
  • SDR(15-29), Cerebrovascular diseases, per 100 000
  • SDR(15-29), Chronic lower respiratory diseases, per 100 000
  • SDR(15-29), Diseases of the circulatory system, per 100 000
  • SDR(15-29), Diseases of the respiratory system, per 100 000
  • SDR(15-29), Influenza, per 100 000
  • SDR(15-29), Ischaemic heart disease, per 100 000
  • SDR(15-29), Other acute respiratory infections, per 100 000
  • SDR(15-29), Pneumonia, per 100 000
  • SDR(15-29), Pulmonary heart disease and other heart diseases, per 100 000
  • SDR(25-64), Asthma, per 100 000
  • SDR(25-64), Cerebrovascular diseases, per 100 000
  • SDR(25-64), Chronic lower respiratory diseases, per 100 000
  • SDR(25-64), Diseases of the circulatory system, per 100 000
  • SDR(25-64), Diseases of the respiratory system, per 100 000
  • SDR(25-64), Influenza, per 100 000
  • SDR(25-64), Ischaemic heart disease, per 100 000
  • SDR(25-64), Other acute respiratory infections, per 100 000
  • SDR(25-64), Pneumonia, per 100 000
  • SDR(25-64), Pulmonary heart disease and other heart diseases, per 100 000
  • SDR(30-44), Asthma, per 100 000
  • SDR(30-44), Cerebrovascular diseases, per 100 000
  • SDR(30-44), Chronic lower respiratory diseases, per 100 000
  • SDR(30-44), Diseases of the circulatory system, per 100 000
  • SDR(30-44), Diseases of the respiratory system, per 100 000
  • SDR(30-44), Influenza, per 100 000
  • SDR(30-44), Ischaemic heart disease, per 100 000
  • SDR(30-44), Other acute respiratory infections, per 100 000
  • SDR(30-44), Pneumonia, per 100 000
  • SDR(30-44), Pulmonary heart disease and other heart diseases, per 100 000
  • SDR(45-59), Asthma, per 100 000
  • SDR(45-59), Cerebrovascular diseases, per 100 000
  • SDR(45-59), Chronic lower respiratory diseases, per 100 000
  • SDR(45-59), Diseases of the circulatory system, per 100 000
  • SDR(45-59), Diseases of the respiratory system, per 100 000
  • SDR(45-59), Influenza, per 100 000
  • SDR(45-59), Ischaemic heart disease, per 100 000
  • SDR(45-59), Other acute respiratory infections, per 100 000
  • SDR(45-59), Pneumonia, per 100 000
  • SDR(45-59), Pulmonary heart disease and other heart diseases, per 100 000
  • SDR(5-14), Diseases of the circulatory system, per 100 000
  • SDR(5-14), Diseases of the respiratory system, per 100 000
  • SDR(5-14), Pneumonia, per 100 000
  • SDR(60-74), Asthma, per 100 000
  • SDR(60-74), Cerebrovascular diseases, per 100 000
  • SDR(60-74), Chronic lower respiratory diseases, per 100 000
  • SDR(60-74), Diseases of the circulatory system, per 100 000
  • SDR(60-74), Diseases of the respiratory system, per 100 000
  • SDR(60-74), Influenza, per 100 000
  • SDR(60-74), Ischaemic heart disease, per 100 000
  • SDR(60-74), Other acute respiratory infections, per 100 000
  • SDR(60-74), Pneumonia, per 100 000
  • SDR(60-74), Pulmonary heart disease and other heart diseases, per 100 000
  • SDR(65+), Asthma, per 100 000
  • SDR(65+), Cerebrovascular diseases, per 100 000
  • SDR(65+), Chronic lower respiratory diseases, per 100 000
  • SDR(65+), Diseases of the circulatory system, per 100 000
  • SDR(65+), Diseases of the respiratory system, per 100 000
  • SDR(65+), Influenza, per 100 000
  • SDR(65+), Ischaemic heart disease, per 100 000
  • SDR(65+), Other acute respiratory infections, per 100 000
  • SDR(65+), Pneumonia, per 100 000
  • SDR(65+), Pulmonary heart disease and other heart diseases, per 100 000
  • SDR(75+), Asthma, per 100 000
  • SDR(75+), Cerebrovascular diseases, per 100 000
  • SDR(75+), Chronic lower respiratory diseases, per 100 000
  • SDR(75+), Diseases of the circulatory system, per 100 000
  • SDR(75+), Diseases of the respiratory system, per 100 000
  • SDR(75+), Influenza, per 100 000
  • SDR(75+), Ischaemic heart disease, per 100 000
  • SDR(75+), Other acute respiratory infections, per 100 000
  • SDR(75+), Pneumonia, per 100 000
  • SDR(75+), Pulmonary heart disease and other heart diseases, per 100 000
  • CDR(0 year), Diseases of the digestive system, per 100 000
  • CDR(1-4), Diseases of the digestive system, per 100 000
  • Deaths(#), Chronic liver disease and cirrhosis
  • Deaths(#), Diseases of genitourinary system
  • Deaths(#), Diseases of musculoskeletal system and connective tissue
  • Deaths(#), Diseases of skin and subcutaneous tissue
  • Deaths(#), Diseases of the digestive system
  • Deaths(#), Ulcer of stomach and duodenum
  • SDR, Chronic liver disease and cirrhosis, per 100 000
  • SDR, Diseases of genitourinary system, per 100 000
  • SDR, Diseases of musculoskeletal system and connective tissue, per 100 000
  • SDR, Diseases of skin and subcutaneous tissue, per 100 000
  • SDR, Diseases of the digestive system, per 100 000
  • SDR, Ulcer of stomach and duodenum, per 100 000
  • SDR(0-14), Chronic liver disease and cirrhosis, per 100 000
  • SDR(0-14), Diseases of genitourinary system, per 100 000
  • SDR(0-14), Diseases of musculoskeletal system and connective tissue, per 100 000
  • SDR(0-14), Diseases of skin and subcutaneous tissue, per 100 000
  • SDR(0-14), Diseases of the digestive system, per 100 000
  • SDR(0-14), Ulcer of stomach and duodenum, per 100 000
  • SDR(0-64), Chronic liver disease and cirrhosis, per 100 000
  • SDR(0-64), Diseases of genitourinary system, per 100 000
  • SDR(0-64), Diseases of musculoskeletal system and connective tissue, per 100 000
  • SDR(0-64), Diseases of skin and subcutaneous tissue, per 100 000
  • SDR(0-64), Diseases of the digestive system, per 100 000
  • SDR(0-64), Ulcer of stomach and duodenum, per 100 000
  • SDR(1-19), Diseases of the digestive system, per 100 000
  • SDR(15-24), Diseases of the digestive system, per 100 000
  • SDR(15-29), Chronic liver disease and cirrhosis, per 100 000
  • SDR(15-29), Diseases of genitourinary system, per 100 000
  • SDR(15-29), Diseases of musculoskeletal system and connective tissue, per 100 000
  • SDR(15-29), Diseases of skin and subcutaneous tissue, per 100 000
  • SDR(15-29), Diseases of the digestive system, per 100 000
  • SDR(15-29), Ulcer of stomach and duodenum, per 100 000
  • SDR(25-64), Chronic liver disease and cirrhosis, per 100 000
  • SDR(25-64), Diseases of genitourinary system, per 100 000
  • SDR(25-64), Diseases of musculoskeletal system and connective tissue, per 100 000
  • SDR(25-64), Diseases of skin and subcutaneous tissue, per 100 000
  • SDR(25-64), Diseases of the digestive system, per 100 000
  • SDR(25-64), Ulcer of stomach and duodenum, per 100 000
  • SDR(30-44), Chronic liver disease and cirrhosis, per 100 000
  • SDR(30-44), Diseases of genitourinary system, per 100 000
  • SDR(30-44), Diseases of musculoskeletal system and connective tissue, per 100 000
  • SDR(30-44), Diseases of skin and subcutaneous tissue, per 100 000
  • SDR(30-44), Diseases of the digestive system, per 100 000
  • SDR(30-44), Ulcer of stomach and duodenum, per 100 000
  • SDR(45-59), Chronic liver disease and cirrhosis, per 100 000
  • SDR(45-59), Diseases of genitourinary system, per 100 000
  • SDR(45-59), Diseases of musculoskeletal system and connective tissue, per 100 000
  • SDR(45-59), Diseases of skin and subcutaneous tissue, per 100 000
  • SDR(45-59), Diseases of the digestive system, per 100 000
  • SDR(45-59), Ulcer of stomach and duodenum, per 100 000
  • SDR(5-14), Diseases of the digestive system, per 100 000
  • SDR(60-74), Chronic liver disease and cirrhosis, per 100 000
  • SDR(60-74), Diseases of genitourinary system, per 100 000
  • SDR(60-74), Diseases of musculoskeletal system and connective tissue, per 100 000
  • SDR(60-74), Diseases of skin and subcutaneous tissue, per 100 000
  • SDR(60-74), Diseases of the digestive system, per 100 000
  • SDR(60-74), Ulcer of stomach and duodenum, per 100 000
  • SDR(65+), Chronic liver disease and cirrhosis, per 100 000
  • SDR(65+), Diseases of genitourinary system, per 100 000
  • SDR(65+), Diseases of musculoskeletal system and connective tissue, per 100 000
  • SDR(65+), Diseases of skin and subcutaneous tissue, per 100 000
  • SDR(65+), Diseases of the digestive system, per 100 000
  • SDR(65+), Ulcer of stomach and duodenum, per 100 000
  • SDR(75+), Chronic liver disease and cirrhosis, per 100 000
  • SDR(75+), Diseases of genitourinary system, per 100 000
  • SDR(75+), Diseases of musculoskeletal system and connective tissue, per 100 000
  • SDR(75+), Diseases of skin and subcutaneous tissue, per 100 000
  • SDR(75+), Diseases of the digestive system, per 100 000
  • SDR(75+), Ulcer of stomach and duodenum, per 100 000
  • CDR(0 year), Certain conditions originating in the perinatal period, per 100 000
  • CDR(0 year), Congenital malformations and chromosomal abnormalities, per 100 000
  • CDR(1-4), Congenital malformations and chromosomal abnormalities, per 100 000
  • Deaths(#), Certain conditions originating in the perinatal period
  • Deaths(#), Congenital malformations and chromosomal abnormalities
  • Deaths(#), females, Complications of pregnancy, childbirth and puerperium
  • SDR, Congenital malformations and chromosomal abnormalities, per 100 000
  • SDR, females, Complications of pregnancy, childbirth and puerperium, per 100 000
  • SDR(0-14), Congenital malformations and chromosomal abnormalities, per 100 000
  • SDR(0-64), Congenital malformations and chromosomal abnormalities, per 100 000
  • SDR(1-19), Congenital malformations and chromosomal abnormalities, per 100 000
  • SDR(15-24), Congenital malformations and chromosomal abnormalities, per 100 000
  • SDR(15-29), Congenital malformations and chromosomal abnormalities, per 100 000
  • SDR(25-64), Congenital malformations and chromosomal abnormalities, per 100 000
  • SDR(30-44), Congenital malformations and chromosomal abnormalities, per 100 000
  • SDR(45-59), Congenital malformations and chromosomal abnormalities, per 100 000
  • SDR(5-14), Congenital malformations and chromosomal abnormalities, per 100 000
  • SDR(60-74), Congenital malformations and chromosomal abnormalities, per 100 000
  • SDR(65+), Congenital malformations and chromosomal abnormalities, per 100 000
  • SDR(75+), Congenital malformations and chromosomal abnormalities, per 100 000
  • CDR(0 year), Sudden and unattended death, cause unknown, per 100 000
  • Deaths(#), Sudden and unattended death, cause unknown
  • Deaths(#), Symptoms, signs, abnormal findings, ill-defined causes
  • SDR, Sudden and unattended death, cause unknown, per 100 000
  • SDR, Symptoms, signs, abnormal findings, ill-defined causes, per 100 000
  • SDR(0-14), Sudden and unattended death, cause unknown, per 100 000
  • SDR(0-14), Symptoms, signs, abnormal findings, ill-defined causes, per 100 000
  • SDR(0-64), Sudden and unattended death, cause unknown, per 100 000
  • SDR(0-64), Symptoms, signs, abnormal findings, ill-defined causes, per 100 000
  • SDR(15-29), Sudden and unattended death, cause unknown, per 100 000
  • SDR(15-29), Symptoms, signs, abnormal findings, ill-defined causes, per 100 000
  • SDR(25-64), Sudden and unattended death, cause unknown, per 100 000
  • SDR(25-64), Symptoms, signs, abnormal findings, ill-defined causes, per 100 000
  • SDR(30-44), Sudden and unattended death, cause unknown, per 100 000
  • SDR(30-44), Symptoms, signs, abnormal findings, ill-defined causes, per 100 000
  • SDR(45-59), Sudden and unattended death, cause unknown, per 100 000
  • SDR(45-59), Symptoms, signs, abnormal findings, ill-defined causes, per 100 000
  • SDR(60-74), Sudden and unattended death, cause unknown, per 100 000
  • SDR(60-74), Symptoms, signs, abnormal findings, ill-defined causes, per 100 000
  • SDR(65+), Sudden and unattended death, cause unknown, per 100 000
  • SDR(65+), Symptoms, signs, abnormal findings, ill-defined causes, per 100 000
  • SDR(75+), Sudden and unattended death, cause unknown, per 100 000
  • SDR(75+), Symptoms, signs, abnormal findings, ill-defined causes, per 100 000
  • CDR(0 year), Accidental drowning and submersion, per 100 000
  • CDR(0 year), Accidental falls, per 100 000
  • CDR(0 year), Accidental poisoning, per 100 000
  • CDR(0 year), Accidents, per 100 000
  • CDR(0 year), Exposure to smoke, fire and flames, per 100 000
  • CDR(0 year), External causes of injury and poisoning, per 100 000
  • CDR(0 year), Motor vehicle traffic accidents, per 100 000
  • CDR(0 year), Transport accidents, per 100 000
  • CDR(1-4), Accidental drowning and submersion, per 100 000
  • CDR(1-4), Accidental falls, per 100 000
  • CDR(1-4), Accidental poisoning, per 100 000
  • CDR(1-4), Accidents, per 100 000
  • CDR(1-4), Exposure to smoke, fire and flames, per 100 000
  • CDR(1-4), External causes of injury and poisoning, per 100 000
  • CDR(1-4), Motor vehicle traffic accidents, per 100 000
  • CDR(1-4), Transport accidents, per 100 000
  • Deaths(#), Accidental drowning and submersion
  • Deaths(#), Accidental falls
  • Deaths(#), Accidental poisoning
  • Deaths(#), Accidental poisoning by alcohol
  • Deaths(#), Accidents
  • Deaths(#), Events of undetermined intent
  • Deaths(#), Exposure to smoke, fire and flames
  • Deaths(#), External causes of injury and poisoning
  • Deaths(#), Homicide and assault
  • Deaths(#), Motor vehicle traffic accidents
  • Deaths(#), Suicide and intentional self-harm
  • Deaths(#), Transport accidents
  • SDR, Accidental drowning and submersion, per 100 000
  • SDR, Accidental falls, per 100 000
  • SDR, Accidental poisoning by alcohol, per 100 000
  • SDR, Accidental poisoning, per 100 000
  • SDR, Accidents, per 100 000
  • SDR, Events of undetermined intent, per 100 000
  • SDR, Exposure to smoke, fire and flames, per 100 000
  • SDR, External causes of injury and poisoning, per 100 000
  • SDR, Homicide and assault, per 100 000
  • SDR, Motor vehicle traffic accidents, per 100 000
  • SDR, Suicide and intentional self-harm, per 100 000
  • SDR, Transport accidents, per 100 000
  • SDR(0-14), Accidental drowning and submersion, per 100 000
  • SDR(0-14), Accidental falls, per 100 000
  • SDR(0-14), Accidental poisoning by alcohol, per 100 000
  • SDR(0-14), Accidental poisoning, per 100 000
  • SDR(0-14), Accidents, per 100 000
  • SDR(0-14), Events of undetermined intent, per 100 000
  • SDR(0-14), Exposure to smoke, fire and flames, per 100 000
  • SDR(0-14), External causes of injury and poisoning, per 100 000
  • SDR(0-14), Homicide and assault, per 100 000
  • SDR(0-14), Motor vehicle traffic accidents, per 100 000
  • SDR(0-14), Suicide and intentional self-harm, per 100 000
  • SDR(0-14), Transport accidents, per 100 000
  • SDR(0-64), Accidental drowning and submersion, per 100 000
  • SDR(0-64), Accidental falls, per 100 000
  • SDR(0-64), Accidental poisoning by alcohol, per 100 000
  • SDR(0-64), Accidental poisoning, per 100 000
  • SDR(0-64), Accidents, per 100 000
  • SDR(0-64), Events of undetermined intent, per 100 000
  • SDR(0-64), Exposure to smoke, fire and flames, per 100 000
  • SDR(0-64), External causes of injury and poisoning, per 100 000
  • SDR(0-64), Homicide and assault, per 100 000
  • SDR(0-64), Motor vehicle traffic accidents, per 100 000
  • SDR(0-64), Suicide and intentional self-harm, per 100 000
  • SDR(0-64), Transport accidents, per 100 000
  • SDR(1-19), Accidental drowning and submersion, per 100 000
  • SDR(1-19), Accidental falls, per 100 000
  • SDR(1-19), Accidental poisoning, per 100 000
  • SDR(1-19), Accidents, per 100 000
  • SDR(1-19), Exposure to smoke, fire and flames, per 100 000
  • SDR(1-19), External causes of injury and poisoning, per 100 000
  • SDR(1-19), Motor vehicle traffic accidents, per 100 000
  • SDR(1-19), Transport accidents, per 100 000
  • SDR(15-24), Accidental drowning and submersion, per 100 000
  • SDR(15-24), Accidental falls, per 100 000
  • SDR(15-24), Accidental poisoning, per 100 000
  • SDR(15-24), Accidents, per 100 000
  • SDR(15-24), Exposure to smoke, fire and flames, per 100 000
  • SDR(15-24), External causes of injury and poisoning, per 100 000
  • SDR(15-24), Motor vehicle traffic accidents, per 100 000
  • SDR(15-24), Transport accidents, per 100 000
  • SDR(15-29), Accidental drowning and submersion, per 100 000
  • SDR(15-29), Accidental falls, per 100 000
  • SDR(15-29), Accidental poisoning by alcohol, per 100 000
  • SDR(15-29), Accidental poisoning, per 100 000
  • SDR(15-29), Accidents, per 100 000
  • SDR(15-29), Events of undetermined intent, per 100 000
  • SDR(15-29), Exposure to smoke, fire and flames, per 100 000
  • SDR(15-29), External causes of injury and poisoning, per 100 000
  • SDR(15-29), Homicide and assault, per 100 000
  • SDR(15-29), Motor vehicle traffic accidents, per 100 000
  • SDR(15-29), Suicide and intentional self-harm, per 100 000
  • SDR(15-29), Transport accidents, per 100 000
  • SDR(25-64), Accidental drowning and submersion, per 100 000
  • SDR(25-64), Accidental falls, per 100 000
  • SDR(25-64), Accidental poisoning by alcohol, per 100 000
  • SDR(25-64), Accidental poisoning, per 100 000
  • SDR(25-64), Accidents, per 100 000
  • SDR(25-64), Events of undetermined intent, per 100 000
  • SDR(25-64), Exposure to smoke, fire and flames, per 100 000
  • SDR(25-64), External causes of injury and poisoning, per 100 000
  • SDR(25-64), Homicide and assault, per 100 000
  • SDR(25-64), Motor vehicle traffic accidents, per 100 000
  • SDR(25-64), Suicide and intentional self-harm, per 100 000
  • SDR(25-64), Transport accidents, per 100 000
  • SDR(30-44), Accidental drowning and submersion, per 100 000
  • SDR(30-44), Accidental falls, per 100 000
  • SDR(30-44), Accidental poisoning by alcohol, per 100 000
  • SDR(30-44), Accidental poisoning, per 100 000
  • SDR(30-44), Accidents, per 100 000
  • SDR(30-44), Events of undetermined intent, per 100 000
  • SDR(30-44), Exposure to smoke, fire and flames, per 100 000
  • SDR(30-44), External causes of injury and poisoning, per 100 000
  • SDR(30-44), Homicide and assault, per 100 000
  • SDR(30-44), Motor vehicle traffic accidents, per 100 000
  • SDR(30-44), Suicide and intentional self-harm, per 100 000
  • SDR(30-44), Transport accidents, per 100 000
  • SDR(45-59), Accidental drowning and submersion, per 100 000
  • SDR(45-59), Accidental falls, per 100 000
  • SDR(45-59), Accidental poisoning by alcohol, per 100 000
  • SDR(45-59), Accidental poisoning, per 100 000
  • SDR(45-59), Accidents, per 100 000
  • SDR(45-59), Events of undetermined intent, per 100 000
  • SDR(45-59), Exposure to smoke, fire and flames, per 100 000
  • SDR(45-59), External causes of injury and poisoning, per 100 000
  • SDR(45-59), Homicide and assault, per 100 000
  • SDR(45-59), Motor vehicle traffic accidents, per 100 000
  • SDR(45-59), Suicide and intentional self-harm, per 100 000
  • SDR(45-59), Transport accidents, per 100 000
  • SDR(5-14), Accidental drowning and submersion, per 100 000
  • SDR(5-14), Accidental falls, per 100 000
  • SDR(5-14), Accidental poisoning, per 100 000
  • SDR(5-14), Accidents, per 100 000
  • SDR(5-14), Exposure to smoke, fire and flames, per 100 000
  • SDR(5-14), External causes of injury and poisoning, per 100 000
  • SDR(5-14), Motor vehicle traffic accidents, per 100 000
  • SDR(5-14), Transport accidents, per 100 000
  • SDR(60-74), Accidental drowning and submersion, per 100 000
  • SDR(60-74), Accidental falls, per 100 000
  • SDR(60-74), Accidental poisoning by alcohol, per 100 000
  • SDR(60-74), Accidental poisoning, per 100 000
  • SDR(60-74), Accidents, per 100 000
  • SDR(60-74), Events of undetermined intent, per 100 000
  • SDR(60-74), Exposure to smoke, fire and flames, per 100 000
  • SDR(60-74), External causes of injury and poisoning, per 100 000
  • SDR(60-74), Homicide and assault, per 100 000
  • SDR(60-74), Motor vehicle traffic accidents, per 100 000
  • SDR(60-74), Suicide and intentional self-harm, per 100 000
  • SDR(60-74), Transport accidents, per 100 000
  • SDR(65+), Accidental drowning and submersion, per 100 000
  • SDR(65+), Accidental falls, per 100 000
  • SDR(65+), Accidental poisoning by alcohol, per 100 000
  • SDR(65+), Accidental poisoning, per 100 000
  • SDR(65+), Accidents, per 100 000
  • SDR(65+), Events of undetermined intent, per 100 000
  • SDR(65+), Exposure to smoke, fire and flames, per 100 000
  • SDR(65+), External causes of injury and poisoning, per 100 000
  • SDR(65+), Homicide and assault, per 100 000
  • SDR(65+), Motor vehicle traffic accidents, per 100 000
  • SDR(65+), Suicide and intentional self-harm, per 100 000
  • SDR(65+), Transport accidents, per 100 000
  • SDR(75+), Accidental drowning and submersion, per 100 000
  • SDR(75+), Accidental falls, per 100 000
  • SDR(75+), Accidental poisoning by alcohol, per 100 000
  • SDR(75+), Accidental poisoning, per 100 000
  • SDR(75+), Accidents, per 100 000
  • SDR(75+), Events of undetermined intent, per 100 000
  • SDR(75+), Exposure to smoke, fire and flames, per 100 000
  • SDR(75+), External causes of injury and poisoning, per 100 000
  • SDR(75+), Homicide and assault, per 100 000
  • SDR(75+), Motor vehicle traffic accidents, per 100 000
  • SDR(75+), Suicide and intentional self-harm, per 100 000
  • SDR(75+), Transport accidents, per 100 000
  • Classification version used to code underlying cause of death (see Definitions)
  • Mid-year female population
  • Mid-year male population
  • Mid-year population
  • Mid-year population, age 0 years
  • Mid-year population, age 1-4 years
  • Mid-year population, age 10-14 years
  • Mid-year population, age 15-19 years
  • Mid-year population, age 20-24 years
  • Mid-year population, age 25-29 years
  • Mid-year population, age 30-34 years
  • Mid-year population, age 35-39 years
  • Mid-year population, age 40-44 years
  • Mid-year population, age 45-49 years
  • Mid-year population, age 5-9 years
  • Mid-year population, age 50-54 years
  • Mid-year population, age 55-59 years
  • Mid-year population, age 60-64 years
  • Mid-year population, age 65-69 years
  • Mid-year population, age 70-74 years
  • Mid-year population, age 75-79 years
  • Mid-year population, age 80-84 years
  • Mid-year population, age 85+ years
  • Prevalence rate cardiovascular diseases
  • Prevalence rate chronic respiratory diseases
  • Prevalence rate mental disorders
  • Prevalence rate musculoskeletal disorders
  • Prevalence rate neoplasms
  • Prevalence rate neurological disorders
  • Prevalence rate sensory impairments
  • Prevalence rate total
  • Years lived with disability cardiovascular diseases
  • Years lived with disability chronic respiratory diseases
  • Years lived with disability mental disorders
  • Years lived with disability musculoskeletal disorders
  • Years lived with disability neoplasms
  • Years lived with disability neurological disorders
  • Years lived with disability sensory impairments
  • Years lived with disability total
  • Access for socially disadvantaged groups
  • Active travel to school
  • Active travel to work
  • Awareness campaign on physical activity
  • Community interventions for older adults
  • Coordination mechanism on HEPA promotion
  • Counselling on physical activity
  • Country HEPA performance
  • Evaluation of HEPA policies
  • Funding for HEPA promotion
  • Infrastructures for leisure-time physical activity
  • Level of cycling and walking
  • Levels of physical activity in adults
  • Levels of physical activity in children and adolescents
  • Physical activity at the workplace
  • Physical activity promotion in schools
  • Physical education in schools
  • Recommendations on physical activity
  • Special target groups
  • Sports Club for Health
  • Sports for All
  • Surveillance of physical activity in health
  • Training of health professionals
  • Training of physical education teachers
  • Population used as denominator, both sexes
  • Social care workers (personal care workers), practicing per 10 000 population
  • Social care workers (personal care workers), practicing, head count
  • Social care workers (personal care workers), professionally active per 10 000 population
  • Social care workers (personal care workers), professionally active, head count
  • Dentists licensed to practice, head count
  • Dentists licensed to practice, per 10 000 population
  • Practising dentists, head count
  • Practising dentists, per 10 000 population
  • Professionally active dentists, head count
  • Professionally active dentists, per 10 000 population
  • Associate professional nursing graduates, head count
  • Associate professional nursing graduates, per 10 000 population
  • Dentists graduates, head count
  • Dentists graduates, per 10 000 population
  • Medical graduates, head count
  • Medical graduates, per 10 000 population
  • Midwives graduates, head count
  • Midwives graduates, per 10 000 population
  • Nursing graduates, head count
  • Nursing graduates, per 10 000 population
  • Pharmacists graduates, head count
  • Pharmacists graduates, per 10 000 population
  • Professional nursing graduates, head count
  • Professional nursing graduates, per 10 000 population
  • Associate nurses employed by hospital in FTE, per 10 000 population
  • Associate nurses employed by hospital in FTE, total number
  • Health care assistants employed by hospital in FTE, per 10 000 population
  • Health care assistants employed by hospital in FTE, total number
  • Hospital employment in FTE, per 10 000 population
  • Other health service providers employed by hospital in FTE, per 10 000 population
  • Other health service providers employed by hospital in FTE, total number
  • Other staff employed by hospital in FTE, per 10 000 population
  • Other staff employed by hospital in FTE, total number
  • Physicians employed by hospital in FTE, per 10 000 population
  • Physicians employed by hospital in FTE, total number
  • Professional nurses and midwives employed by hospital in FTE, per 10 000 population
  • Professional nurses and midwives employed by hospital in FTE, total number
  • Total hospital employment in FTE, total number
  • Associate professional nurses employed by hospital, head count
  • Associate professional nurses employed by hospital, per 10 000 population
  • Health care assistants employed by hospital, head count
  • Health care assistants employed by hospital, per 10 000 population
  • Hospital employment, per 10 000 population
  • Nurses and midwives employed by hospital, head count
  • Nurses and midwives employed by hospital, per 10 000 population
  • Other health service providers employed by hospital, head count
  • Other health service providers employed by hospital, per 10 000 population
  • Other staff employed by hospital, head count
  • Other staff employed by hospital, per 10 000 population
  • Physicians employed by hospital, head count
  • Physicians employed by hospital, per 10 000 population
  • Total hospital employment, head count
  • Midwives licensed to practice, head count
  • Midwives licensed to practice, per 10 000 population
  • Practising midwives, head count
  • Practising midwives, per 10 000 population
  • Professionally active midwives, head count
  • Professionally active midwives, per 10 000 population
  • Associate professional nurses, licensed to practice, head count
  • Associate professional nurses, licensed to practice, per 10 000 population
  • Nurses licensed to practice, per 10 000 population
  • Professional nurses, licensed to practice, head count
  • Professional nurses, licensed to practice, per 10 000 population
  • Total nurses licensed to practice, head count
  • Associate professional nurses, practising, head count
  • Associate professional nurses, practising, per 10 000 population
  • Practising nurses, per 10 000 population
  • Professional nurses, practising, head count
  • Professional nurses, practising, per 10 000 population
  • Total practising nurses, head count
Countries (0/66)
Select a country, multiple countries or a group of countries in the “country groups”.
Countries
Country groups
Show average value (1/13)
Show average value for countries within the following country groups:
Country groups
Windowed icon
To start working, select an indicator, country/several countries/group of countries. You can also see the average value for countries by selecting a group of countries in the "average value" tab
Dimension for axis X
Dimension for axis Y
Info icon
Title
Share icon
Download as:
Export as:
Share icon
enable disable selected item
Save current chart
Fullscreen icon
Windowed icon
  • Line chart
  • Bubble chart
  • Map
  • Bar chart
  • Table
From
To
Tooltip is visible for up to 16 countries
Axis x
Select indicator
Axis y
Optional indicator
Highlight options
  • One color for all countries
  • WHO European Region
  • Members of the European Union
  • Members of the EU before May 2004 (EU15)
  • Members of the EU after May 2004 (EU13)
  • Members of the EU before Feb 2020
  • Commonwealth of Independent States
  • Central Asian Republics Information Network members (CARINFONET)
  • South-eastern Europe Health Network members (SEEHN)
  • Nordic countries
  • Small countries
  • HBSC countries
  • WHO Euro surveillance countries
  • Western Balkans
play pause
Chart export
  • x px
{Countries}
{"NoChartDataAvailable":"No chart data available.","NoActualDataLegend":"Missing data for selected year (nearest available year is displayed)","WindowedHint":"Windowed","CountriesDescription":"Select a country, multiple countries or a group of countries in the “country groups”.","ShowAverageValueLabel":"Show average value for countries within the following country groups:","EditNameHint":"Edit name","MapFootnoteProductionLink":"https://gateway.euro.who.int/en/","PreviewEmbedLabel":"Preview embedding","DataNotAvailableMapLabel":"White color: data not available.","SelectedIndicators":"Selected indicators","MissingBubbleSizeDataFootnote":"Missing bubble size data","BubbleSizeFromLabel":"from","BubbleSizeToLabel":"to","LoadLabel":"Load","DeleteHint":"Delete","AxisXCaption":"Select indicator","SavedChartsLabel":"Saved charts","UpdateLabel":"Update","AverageValue":"Show average value","MapFootnoteWHO":"© WHO Regional Office for Europe 2026. All rights reserved.","BubbleChartHint":"Bubble chart","AxisYCaption":"Optional indicator","DetChartDownloadSVG":"SVG ","SharingOptionLabel":"Sharing options","HighlightOptions":"Highlight options","IHoverHint":"Detailed information","SelectedCountriesLabel":"Selected countries","IndicatorGroupsTitle":"Indicator groups","StopLabel":"Stop","SizeOfBubbleFootnote":"Size of bubble:","AxisTitleTemplate":"<nameOfIndicator><dimension><year> (<unitType>)","ShowTrace":"Bubble trail","LatestDataAvailableHtml":"Latest data","DetChartDownloadPNG":"PNG ","DefaultChartNameLabel":"Chart1","ToXls":"Excel","DirectLinkLabel":"Direct link","BarChartHint":"Bar chart","MapFootnoteSource":"Source: European Health for All family of databases","LineChartHInt":"Line chart","CopyLinkLabel":"Copy link","FromLabel":"From:","IndicatorsTitle":"Indicators","AxisYPopup":"Axis y","viewSavedCharts":"Saved charts","DimensionCaptionAxisX":"Dimension for axis X","ZoomInPopup":"Zoom in","LatestDataAvailableAtIndicatorTitle":"Latest data","DimensionCaptionAxisY":"Dimension for axis Y","MapFootnoteDetail":"The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.","NoDataSelected":"To start working, select an indicator, country/several countries/group of countries. You can also see the average value for countries by selecting a group of countries in the \"average value\" tab","ChooseIndicatorsText2":"Filter through subjects or pick a database you are interested in.","NoCountryDataAvailableTemplate":"No data available (xx {country}):","CountriesTitle":"Countries","EmbedCodeLabel":"Embed code","DetChartDownloadJPEG":"JPG ","BookmarksAbsentInfo":"There are no bookmarks yet.","ChooseIndicators":"Choose indicators ","ShowLabel":"Show:|5 years|10 years|15 years|All years","HighlightOptionsLabel":"Highlight options:","MapFootnoteProductionLinkText":"WHO European Health Information Gateway, gateway.euro.who.int","DeleteBookmarkConfirm":"Are you sure you want to delete chart from bookmarks?","DownloadHint":"Download","ToLabel":"To:","ResetZoomLabel":"Reset zoom","MapChartHint":"Map","DataSetNoteLabel":"Data set notes:","CountriesGroupTitle":"Country groups","ExportDownloadIndicator":"Download as:","ShowTimeLabel":"Show time control","ChooseIndicatorsText1":"Select one or more indicator to visualize data.","FullscreenHint":"Fullscreen","MapFootnoteProduction":"Map production:","AxisXPopup":"Axis x","DetChartPrint":"PRINT","ZoomOutPopup":"Zoom out","WidthLink":"Width","LineChartFootnote":"[n]-year rolling average is applied to Small Countries.","AveragesBookmarkValue":"Show average values([number])","PlayLabel":"Play","OneColorForAllCountries":"One color for all countries","TableChartHint":"Table","ShareHint":"Share","DetChartDownloadPDF":"PDF ","SaveChartHeader":"Save current chart","DetailedInformation":"Detailed information","SelectBubble":"Select","ToCsv":"CSV","YearLabel":"Year:","ExportSelectedIndicators":"Export as:","SaveLabel":"Save","indicatorSelectPlaceholder":"Select an indicator","indicatorSelectDescription":"Select an indicator or multiple indicators ","indicatorSelectedPlaceholder":"Selected indicator","indicatorSelectTitle":"Indicator","indicatorGroupSelectedPlaceholder":"Selected indicator group","indicatorGroupSelectDescription":"Select an indicator group or multiple indicator groups","indicatorGroupSelectPlaceholder":"Select an indicator group","indicatorGroupSelectTitle":"Indicator groups","countrySelectedPlaceholder":"Selected country","countrySelectTitle":"Country","countrySelectDescription":"Select a country or multiple countries ","countrySelectPlaceholder":"Select a country","countryGroupSelectDescription":"Select a country group or multiple country groups","countryGroupSelectTitle":"Country groups","countryGroupSelectPlaceholder":"Select a country group","countryGroupSelectedPlaceholder":"Selected country group","visLatestTableCol":"Latest data<br/>available","clearOptionsBtn":"Clear","allSelectedPlaceholder":"All"}
Data, Artificial Intelligence and Digital Health unit (DAD)
Health Systems (HSD) Division
World Health Organization

Contact us

Regional Office for Europe
UN City
Marmorvej 51
DK-2100 Copenhagen
Denmark
Tel.: +45 45 33 70 00
Fax: +45 45 33 70 01
euhiudata@who.int

Follow us and share

API tutorials on YouTube Cite the Gateway

Help and FAQ

About the Gateway Frequently asked questions European Health Information Initiative Terms of use of the WHO website Data sharing license Privacy Sitemap

Tools

WHO/Europe Data Warehouse WHO/Europe API

Join us

Youtube logo Facebook logo Twitter logo Instagram logo

Gateway: v4.75.0, DW: v3.12.3262.71

© 2026 WHO